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Reactive oxygen species (ROS) generated during various metabolic and biochemical 
reactions has multifareous effects that include oxidative damage to DNA leading to various human 
degenerative and autoimmune diseases. ROS are formed from oxygen in one electron reduction 
reactions and include superoxide anion, hydrogen peroxide and hydroxyl radical. 
Chronic inflammation is associated with considerable tissue injury resulting from perpetual 
stimulation of phagocytic cells by bacterial and immunological stimuli releasing reactive oxygen 
species. The hydroxyl radical ('OH), formed during inflammatory processes is an extremely 
reactive oxidizing radical with a short half life and interact indiscriminately with all components of 
the DNA molecule. 
Systemic lupus erythematosus (SLE) and progressive systemic sclerosis (PSS) are the 
chronic inflammatory disorders characterized by the presence of autoantibodies targeted against 
various intracellular proteins and nucleic acids. SLE is considered to be the prototype of a 
spontaneous immune complex disease in which anti-DNA antibody-DNA deposit in the tissues 
causing inflammation. Anti-double stranded DNA antibodies are the serologic hallmarks of SLE. 
PSS is serologically associated with the emergence of autoantibodies to SC1-70 (DNA 
topoisomerase I, PM-SC1, U3-RNP) with different incidence and disease specificities. 
The origin of these autoantibodies and their etiology is still in dilemma The binding of SLE 
autoantibodies to ROS-modified DNA, DNA-psoralen adduct, brominated DNA, DNA-RNA 
hybrids and various single and double stranded polynucleotides have been reported 
In the present study, a ribohomopolymer, polyguanylic acid [poly(G)] was modified with 
hydroxyl radical, generated by irradiation of hydrogen peroxide with 254 ran UV light. The 
modification of poly(G) was analysed by UV and CD spectroscopic techniques. When compared 
with the spectrum of native poly(G), ROS-poly(G) exhibited hypochromicity at X.^, 253 ran. This 
could be due to structural alterations of guanine base in ROS-poly(G). The result was 
substantiated by UV difference spectra, exhibiting an undefined peak, indicating the marked 
hypochromicity of modified poly(G). Pjoly(G) interacts with poly(C) to form an extremely stable 
poly(G).poly(C) complex. The change in absorbance ratio (A^/A^J from 1.82 in case of 
native poly(G) to 1.7 for ROS-poly(G) and 2.21 for poly(G).poly(C) to 1.78 for ROS-
poly(G).poly(C) complex suggests structural and conformational changes in hydroxyl 
modified poly(G). CD spectrum showed no conformational transition but a remarkable 
loss in ellipticity of modified poly(G). 
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The strand breaks in modified poly(G) was detected by Sephadex G 200 gel 
chromatography, densitometric scanning, agarose gel electrophoresis and gel 
diffusion. Sephadex G 200 gel chromatography showed 52.3% modification of 
poly(G) after hydroxyl treatment. Densitometric scanning of ROS-poly(G) showed 
low intensity and high mobility. This is due to the formation of strand breaks in 
modified poly(G). The enhanced mobility of ROS-poly(G) on agarose gel 
substantiated the formation of strand breaks, resulting in the formation of low 
molecular weight species. Gel diffusion experiments reiterate the fragmentation of 
poly(G) after hydroxyl modification. 
Hydroxyl radicals have been known to induce guanine base modifications in DNA. 
UV spectra of acid hydrolysed poly(G) showed a distinct peak at 273 nm, indicating 
the release of guanine base from the sugar-phosphate backbone. The broadening of 
absorption maxima of acid hydrolysed ROS-poly(G) at 273 nm, in contrast to sharp 
peak [of native poly(G)] indicated the structural perturbations of guanine base in 
modified poly(G). The ion exchange profile of acid hydrolysed ROS-poly(G) on DEAE 
Sephadex A 25 column showed 75.8% modification of guanine base. 
Native and ROS-poly(G) were used to induce antibodies in rabbits. Both were 
found to be a potent immunizing stimulus, inducing high titre antibodies. The antigenic 
specificity of the induced antibodies was studied by competition ELISA. The immunogen 
showed a high degree of specificity for the induced antibodies. Protein A-Sepharose 
purified immune IgG showed higher specificity as compared to serum. The antibody 
diversity was checked by using various nucleic acid inhibitors. 
Calf thymus DNA, buffalo thymus RNA, poly(I), poly(C), guanine base and 
their ROS-modified forms were used as inhibitors in inhibition ELISA. It was 
observed that anti-native poly(G) antibodies are more specific towards the native 
form of conformers than their ROS-modified forms. Anti-ROS-poly(G) antibody showed 
preferential recognition of ROS'-modified part of inhibitor than their unmodified 
counterparts. ROS-guanine was inhibitory to an extent of 56%, whereas, native guanine 
showed only 21% inhibition. The data indicates that anti-ROS-poly(G) antibodies are 
more specific to ROS-modified epitopes on guanine. The polyspecific behavior of anti-
ROS-poly(G) antibodies resembles the binding characteristics of SLE anti-DNA 
I l l 
autoantibodies. 
Earlier reports demonstrated guanine to be highly susceptible to hydroxyl 
radical attack leading to the formation of 8-hydroxyguanine. Modification of guanine 
base by ROS, could therefore, generate potential epitopes against which antibodies 
are elicited. 
In the present study, SLE sera from patients were investigated for the 
presence of naturally occurring anti-double stranded DNA autoantibodies. The 
binding specificity of SLE autoantibodies was analysed by inhibition ELISA. Native 
and ROS-poly(G) were used as competitors in the anti-DNA autoantibody binding 
to native DNA. Direct binding ELISA results demonstrate the preferential 
recognition of ROS-poly(G) over native poly(G) in all serum samples. In inhibition 
ELISA, ROS-poly(G) showed relatively high per cent inhibitions than that of native 
poly(G). Band shift assay further substantiated the binding of native and modified 
poly(G) with anti-DNA autoantibodies. Direct binding ELISA of Protein A-Sepharose 
purified SLE IgG showed an appreciable binding to native and ROS-poly(G). ROS-
poly(G) as compared to native DNA provides higher inhibitory potential to SLE 
anti-DNA autoantibodies, which points out the presence of unique potential epitopes 
on modified poly(G), most probably due to the formation of 8-OH-G, a marker of 
oxidative DNA damage in SLE. 
Moreover, serum from PSS patients were investigated for the presence of 
autoantibodies to native and ROS-poly(G), and it was observed that ROS-poly(G) is 
recognised to a greater extent than native poly(G). Band shift assay of purified IgG 
from PSS sera showed the formation of immune complexes with native and ROS-
poly(G), reiterating the direct binding and inhibition results. 
These results demonstrate that guanine residues of DNA and RNA are highly 
susceptible to ROS-mediated damage in the chronic inflammatory disorders, SLE and 
PSS. 
The frequency of single stranded anti-RNA antibodies, particularly the anti-poly(G) 
autoantibodies were investigated in SLE and PSS serum samples. All PSS sera showed 
the formation of precipitating immune complexes with native and ROS-poly(G) by 
counterimmunoelectrophoresis, whereas, eight out of twelve SLE sera (67% frequency) 
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were positive by this technique. This could suggest the higher prevalence of anti-RNA 
antibodies in scleroderma which is due to ribose moiety of RNA and is quite distinct 
from those of anti-DNA antibodies in SLE. 
DNA-anti-DNA antibody complexes are deposited in the glomeruli of certain 
individuals with systemic lupus erythematosus. Rats immunized with native and 
ROS-poly(G) induced high titre antibodies. Kidney sections of the immunized rats 
were tested for immune complexes deposition in the glomerulus. Immunofluorescence 
revealed the deposition of immune complexes in the glomeruli of the kidney as 
evident by an apple green fluorescence. The immune complex deposition may cause 
kidney inflammation and tissue destruction. These findings could suggest that the 
antibody-ligand interactions participate in immune complex formation in individuals with 
lupus and the predominant autoantibody autoantigen interaction(s) influence both the 
morphologic and clinical expression of nephritis. 
In conclusion, the hydroxyl radicals cause extensive damage to guanine residues. 
The possibility of oxidatively modified guanine base of DNA and RNA, acting as a 
stimuli in inducing lupus anti-DNA autoantibodies and anti-RNA autoantibodies in PSS is 
indicated by this study. 
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Reactive oxygen species (ROS) generated during various metabolic and biochemical 
reactions has multifareous effects that include oxidative damage to DNA leading to various human 
degenerative and autoimmune diseases. ROS are formed from oxygen in one electron reduction 
reactions and include superoxide anion, hydrogen peroxide and hydroxyl radical. 
Chronic inflammation is associated with considerable tissue injury resulting from perpetual 
stimulation of phagocytic cells by bacterial and immunological stimuli releasing reactive oxygen 
species. The hydroxyl radical (*OH), formed during inflammatory processes is an extremely 
reactive oxidizing radical with a short half life and interact mdiscriminately with all components of 
the DNA molecule. 
Systemic lupus erythematosus (SLE) and progressive systemic sclerosis (PSS) are the 
chronic inflammatory disorders characterized by the presence of autoantibodies targeted against 
various intracellular proteins and nucleic acids. SLE is considered to be the prototype of a 
spontaneous immune complex disease in which anti-DNA antibody-DNA deposit in the tissues 
causing inflammation. Anti-double stranded DNA antibodies are the serologic hallmarks of SLE. 
PSS is serologically associated with the emergence of autoantibodies to SC1-70 (DNA 
topoisomerase I, PM-SC1, U3-RNP) with different incidence and disease specificities. 
The origin of these autoantibodies and their etiology is still in dilemma. The binding of SLE 
autoantibodies to ROS-modified DNA, DNA-psoralen adduct, brominated DNA, DNA-RNA 
hybrids and various single and double stranded polynucleotides have been reported. * 
In the present study, a ribohomopolymer, polyguanylic acid [poly(G)] was modified with 
hydroxyl radical, generated by irradiation of hydrogen peroxide with 254 nm UV light. The 
modification of poly(G) was analysed by UV and CD spectroscopic techniques. When compared 
with the spectrum of native poly(G), ROS-poly(G) exhibited hypochromicity at Xnm, 253 nm. This 
could be due to structural alterations of guanine base in ROS-poly(G). The result was 
substantiated by UV difference spectra, exhibiting an undefined peak, indicating the marked 
hypochromicity of modified poly(G). Poly(G) interacts with poly(C) to form an extremely stable 
poly(G).poly(C) complex. The change in absorbance ratio ( A ^ A ^ from 1.82 in case of 
native poly(G) to 1.7 for ROS-poly(G) and 2.21 for poly(G).poly(C) to 1.78 for ROS-
poly(G).poly(C) complex suggests structural and conformational changes in hydroxyl 
modified poly(G). CD spectrum showed no conformational transition but a remarkable 
loss in ellipticity of modified poly(G). 
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The strand breaks in modified poly(G) was detected by Sephadex G 200 gel 
chromatography, densitometric scanning, agarose gel electrophoresis and gel 
diffusion. Sephadex G 200 gel chromatography showed 52.3% modification of 
poly(G) after hydroxyl treatment. Densitometric scanning of ROS-poly(G) showed 
low intensity and high mobility. This is due to the formation of strand breaks in 
modified poly(G). The enhanced mobility of ROS-poly(G) on agarose gel 
substantiated the formation of strand breaks, resulting in the formation of low 
molecular weight species. Gel diffusion experiments reiterate the fragmentation of 
poly(G) after hydroxyl modification. 
Hydroxyl radicals have been known to induce guanine base modifications in DNA. 
UV spectra of acid hydrolysed poly(G) showed a distinct peak at 273 nm, indicating 
the release of guanine base from the sugar-phosphate backbone. The broadening of 
absorption maxima of acid hydrolysed ROS-poly(G) at 273 nm, in contrast to sharp 
peak [of native poly(G)] indicated the structural perturbations of guanine base in 
modified poly(G). The ion exchange profile of acid hydrolysed ROS-poly(G) on DEAE 
Sephadex A 25 column showed 75.8% modification of guanine base. 
Native and ROS-poly(G) were used to induce antibodies in rabbits. Both were 
found to be a potent immunizing stimulus, inducing high titre antibodies. The antigenic 
specificity of the induced antibodies was studied by competition ELISA. The immunogen 
showed a high degree of specificity for the induced antibodies. Protein A-Sepharose 
purified immune IgG showed higher specificity as compared to serum. The antibody 
diversity was checked by using various nucleic acid inhibitors. 
Calf thymus DNA, buffalo thymus RNA, poly(I), poly(C), guanine base and 
their ROS-modified forms were used as inhibitors in inhibition ELISA. It was 
observed that anti-native poly(G) antibodies are more specific towards the native 
form of conformers than their ROS-modified forms. Anti-ROS-poly(G) antibody showed 
preferential recognition of ROST-modified part of inhibitor than their unmodified 
counterparts. ROS-guanine was inhibitory to an extent of 56%, whereas, native guanine 
showed only 21% inhibition. The data indicates that anti-ROS-poly(G) antibodies are 
more specific to ROS-modified epitopes on guanine. The polyspecific behavior of anti-
ROS-poly(G) antibodies resembles the binding characteristics of SLE anti-DNA 
I l l 
autoantibodies. 
Earlier reports demonstrated guanine to be highly susceptible to hydroxyl 
radical attack leading to the formation of 8-hydroxyguanine. Modification of guanine 
base by ROS, could therefore, generate potential epitopes against which antibodies 
are elicited. 
In the present study, SLE sera from patients were investigated for the 
presence of naturally occurring anti-double stranded DNA autoantibodies. The 
binding specificity of SLE autoantibodies was analysed by inhibition ELISA. Native 
and ROS-poly(G) were used as competitors in the anti-DNA autoantibody binding 
to native DNA. Direct binding ELISA resul ts demonstrate the preferential 
recognition of ROS-poly(G) over native poly(G) in all serum samples. In inhibition 
ELISA, ROS-poly(G) showed relatively high per cent inhibitions than that of native 
poly(G). Band shift assay further substantiated the binding of native and modified 
poly(G) with anti-DNA autoantibodies. Direct binding ELISA of Protein A-Sepharose 
purified SLE IgG showed an appreciable binding to native and ROS-poly(G). ROS-
poly(G) as compared to native DNA provides higher inhibitory potential to SLE 
anti-DNA autoantibodies, which points out the presence of unique potential epitopes 
on modified poly(G), most probably due to the formation of 8-OH-G, a marker of 
oxidative DNA damage in SLE. 
Moreover, serum from PSS patients were investigated for the presence of 
autoantibodies to native and ROS-poly(G), and it was observed that ROS-poly(G) is 
recognised to a greater extent than native poly(G). Band shift assay of purified IgG 
from PSS sera showed the formation of immune complexes with native and ROS-
poly(G), reiterating the direct binding and inhibition results. 
These results demonstrate that guanine residues of DNA and RNA are highly 
susceptible to ROS-mediated damage in the chronic inflammatory disorders, SLE and 
PSS. 
The frequency of single stranded anti-RNA antibodies, particularly the anti-poly(G) 
autoantibodies were investigated in SLE and PSS serum samples. All PSS sera showed 
the formation of precipitating immune complexes with native and ROS-poly(G) by 
counterimmunoelectrophoresis, whereas, eight out of twelve SLE sera (67% frequency) 
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were positive by this technique. This could suggest the higher prevalence of anti-RNA 
antibodies in scleroderma which is due to ribose moiety of RNA and is quite distinct 
from those of anti-DNA antibodies in SLE. 
DNA-anti-DNA antibody complexes are deposited in the glomeruli of certain 
individuals with systemic lupus erythematosus. Rats immunized with native and 
ROS-poly(G) induced high titre antibodies. Kidney sections of the immunized rats 
were tested for immune complexes deposition in the glomerulus. Immunofluorescence 
revealed the deposition of immune complexes in the glomeruli of the kidney as 
evident by an apple green fluorescence. The immune complex deposition may cause 
kidney inflammation and tissue destruction. These findings could suggest that the 
antibody-ligand interactions participate in immune complex formation in individuals with 
lupus and the predominant autoantibody autoantigen interaction(s) influence both the 
morphologic and clinical expression of nephritis. 
In conclusion, the hydroxyl radicals cause extensive damage to guanine residues. 
The possibility of oxidatively modified guanine base of DNA and RNA, acting as a 
stimuli in inducing lupus anti-DNA autoantibodies and anti-RNA autoantibodies in PSS is 
indicated by this study. 
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The structure of nucleic acids has been a research target for decades, ever since 
Watson and Crick (1953) discovered the double-stranded helical structure of DNA. 
More information has been obtained about the structure of DNA molecules in crystals 
and fibres through X-ray diffraction (Langridge et al, 1960; Fuller and Wilkins, 1965; 
Arnott and Hukins, 1972; Shakked and Kennard, 1983). The solution structure of 
nucleic acids which may not be directly predictable from their crystal or fibre structures, 
depend on the variation of environmental conditions, such as solvent, pH, temperature 
and ionic strength (Clore and Gronenborn, 1985; Wilson and Yang, 1986; Patel et al, 
1987; Antao et al, 1988; Flemming et al, 1988; Nerdal et al, 1988; Fukudome et 
al, 1990; Zhong and Johnson, 1990). However, the structure of nucleic acids in 
solution is more difficult to obtain, although a number of spectroscopic techniques have 
been used to investigate aspects of nucleic acid structure in various solutions (Clore and 
Gronenborn, 1985; Wilson and Yang, 1986; Flemming et al, 1988; Zhong and Johnson, 
1990). It is well known that the right-handed double-helical DNA can exist in A, B, 
C and D conformations, whereas the left handed polynucleotide can adopt the Z-
structure (Saenger, 1984). Though RNA prefers the A type of conformation (Woo et 
al, 1980), the formation of the left handed Z-RNA has also been reported (Uesugi et 
al, 1984; Nakamura et al., 1985; Dayis et al, 1986; Krzyzaniak et al, 1994). It 
has been demonstrated that the deoxyguanosine moieties play an important role in 
producing the left handed Z-structure in poly(dG-dC) (Wang et al, 1979), while the 
deoxyguanosine residues are responsible for the poly(dA).poly(dT) conformational 
transitions (Uesugi et al, 1984; Nakamura et al, 1985). Triple stranded nucleic acids 
have been found to exist in DNA using a variety of hydrogen bonding arrangements in 
the major groove of B-DNA (Camerini-Otero and Hseih, 1993). Another unique 
structure is the quadruple-stranded nucleic acids (Rich, 1958). The X-ray diffraction 
pattern of polyguanylic acid and polyinosinic acid indicate a four-stranded structure 
(Rich, 1958; Zimmerman et al., 1975; Simard and Savoie, 1994). The different 
conformations adopted by DNA and RNA reflects the enormous versatility that is 
inherent in the molecule. 
Antigenicity of DNA 
DNA is a complex macromolecule with immunologic properties that have been both 
misconstrued and underappreciated. Although anti-DNA antibodies are considered 
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diagnostic of systemic lupus erythematosus (SLE), they are expressed in 
association with multiple antinuclear antibody specificities, suggesting a role for both 
generalized as well as antigen specific immune abnormalities in their etiology (Pisetsky, 
1992; 1997). The notion that DNA is immunologically inactive derives primarily from 
efforts to replicate lupus by immunization of normal animals with DNA, have been 
unsuccesful (Messina et al., 1993). When presented with the protein carrier methylated 
BSA and administered in adjuvant, mammalian DNA elicits poor responses to single-
stranded DNA and fails to induce antibodies to double stranded DNA, the serologic 
hallmark of SLE (Madaio et al., 1984). However, DNA complexes with a synthetic 
immunogenic peptide Fus-1 induces an anti-double stranded DNA response in mice 
(Desai et al., 1993). This led to the conclusion that antigen drive in lupus involves 
either a substance other than DNA or DNA in a form (e.g., nucleosomes) that is not 
readily mimicked by artificial complexes (Burlingame et al., 1993; Mohan et al., 1993). 
Since the antibody reactivity to both single and double stranded forms appears 
independent of DNA species origin, these finding suggests recognition of conserved 
conformational determinants (e.g., helical backbone of B-DNA) and a lack of DNA 
sequence microheterogeneity on antigenicity (Stollar, 1975; Pisetsky, 1993). 
In contrast to mammalian DNA which is poorly immunogenic (Isenberg et al., 
1994), bacterial DNA can induce strong antibody response (Pisetsky, 1997). Contrary 
to prevailing dogma that anti-DNA antibodies occur only in SLE, the normal human sera 
showed significant binding to DNA from two bacterial species, Micrococcus 
lysodeikticus and Staphylococcus epidermidis, and from BK polyoma-virus as well 
(Fredriksen et al., 1994; Rekvig et al., 1995). Thus during either infection or 
colonization, bacterial, or viral DNA could drive the production of antibodies to 
sequence regions absent from host DNA. The immune response to foreign DNA is 
analogous to that of foreign proteins in that, it does not require T-cell recognition. The 
antibodies are of IgG2 isotype, where as lupus anti-DNA are predominantly IgGl and 
IgG3. (Zouali et al., 1984; Kay et al., 1988; Pisetsky, 1997; Pisetsky and Drayton, 
1997; Tsujimura et al., 1997). This pattern of isotype expression suggests that the 
responses to foreign DNA are distinct from the lupus anti-DNA response, which 
appears T cell dependent (Robertson et al., 1992). The antibodies elicited by 
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immunization of bacterial DNA in normal mice, bind both single stranded and double 
stranded DNA of the immunogen. The autoimmune NZB/NZW mice, immunized with 
either bacterial DNA or BK viral DNA, produce cross reactive antibodies to mammalian 
double stranded DNA (Fredriksen et al., 1994; Gilkeson et al., 1995). The antigenic 
specificities of these induced antibodies are comparable to the SLE anti-DNA 
autoantibodies (Gilkeson et al., 1993). Thus the presence of bacterial DNA sequences 
in immune complexes in lupus sera indicate the possibility of foreign DNA driven 
immune response. Low molecular weight DNA was found in the DNA-anti-DNA 
complexes of lupus patients and is enriched in CG content (Sano et al., 1983). The 
CG rich DNA regions has the tendency to form Z-DNA, which is highly immunogenic. 
Free Radical Biochemistry 
For many years, free radicals were dismissed as either non-existent in biological 
systems or simply an unimportant curiosity. Now free radical presence is undisputed and 
their role in health and disease has become widely accepted into the biochemical and 
medical orthodoxy. 
A free radical is a chemical species, possessing a very short half life that contains 
one or more unpaired electrons. As such, free radicals can be formed by homolytic 
fission of a covalent bond, or by the loss/addition of a single electron from/to a normal 
molecule. It is now well established that free radicals and other reactive oxygen species 
(ROS) are continously produced in vivo, and can damage most cellular components 
(Martinez-Cayuela, 1995). Many toxic agents also generate intracellular oxygen radicals. 
In consequence, several antioxidant defense systems limit their damaging effects and also 
repair systems prevent the accumulation of oxidatively-damaged molecules (Fridovich, 
1989; Halliwell and Gutteridge, 1989; Sies, 1985; 1991). Oxidative damage refers to 
the damages formed by ROS that accumulate with time in the DNA of animal cells 
(Ames et al., 1993). 
The term reactive oxygen species includes not only oxygen-centered radicals as 
superoxide (02") and hydroxyl ('OH), but also some non-radical derivatives of oxygen, 
such as hydrogen peroxide (H202), singlet oxygen ('02), hypochlorous acid (HOCl) and 
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ozone (03), that are involved in oxygen radical production. There are numerous 
mechanisms for the generation of free radicals in vivo (Simic et al., 1988; Emerit et 
al., 1990). Components of the electron carriers that bring reducing equivalents to 
cytochrome oxidase are subject to oxidation by oxygen to produce the superoxide free 
radical anion (02 ') (Ames et al., 1993). 
Hydrogen peroxide that escapes destruction can act as an oxidizing agent, but is 
not especially reactive. Its main significance lies in it being a source of hydroxyl radicals 
in the presence of reduced transition metal ions via Fenton reaction (Fenton, 1894; 
Halliwell and Gutteridge, 1990). 
H202 + Fe27Cu+ > 'OH + OH" + Fe37Cu2 
In a biosystem, where reducing conditions prevail, Fe2VCu+ can be regenerated 
easily by an electron donor, 
Fe37Cu2+ + e" > Fe27Cu+ 
The non-catalysed Haber-Weiss reaction is the reaction of superoxide directly with 
hydrogen peroxide (Haber and Weiss, 1934). 
02 ' + H202 > OH + OH + 02 
The hydroxyl radical so formed in vivo, is an extremely reactive oxidizing radical 
that will react with most biomolecules at diffusion-controlled rates. It, therefore, does not 
diffuse a significant distance within a cell before reacting and has an extremely short 
half-life, but is capable of causing great damage within a limited radius at its site of 
production. 
Beauchamp and Fridovich (1970) proposed that toxicity of superoxide radical and 
hydrogen peroxide could involve their conversion into a much more reactive hydroxyl 
radical. Nitric Oxide, another reactive oxygen species interact with superoxide radical to 
generate peroxynitrite which in turn forms hydroxyl radicals (Saran et al, 1990; Inoue 
and Kawanishi, 1995). 
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Free Radical Production in Cells 
Free radicals are generally produced in cells by electron transfer reactions 
mediated by the action of enzymes or through the redox chemistry of transition metal 
ions. Their production in animal cells can either be accidental or deliberate. Some 
enzymes utilize a free radical at their active site in the process of catalysis, for 
example, ribonucleotide reductase (Reichard and Ehrenberg, 1983; Stubbe, 1990). 
Activated phagocytes also deliberately generate superoxide as part of their bactericidal 
role (Babior, 1978). The major source of free radicals in cells is electron 'leakage' 
from electron transport chains, such as those in mitochondria and in the endoplasmic 
reticulum, to molecular oxygen, generating superoxide. Flavin oxidases located in the 
peroxisomes also produce superoxide or hydrogen peroxide. Autooxidation of certain 
compounds including ascorbic acid (Vitamin C), thiols (e.g., glutathione, cysteine), 
adrenaline and flavin co-enzymes are also good sources of superoxide. This accidental 
production of free radicals is kept to a minimum, by the high efficiency of enzyme-
mediated electron transfer and by keeping metal ions tightly sequestered, the fundamental 
means of preventive antioxidant defence. Such precautions are not completely efficient 
and leads to the production of free radicals during normal metabolic activity. Several 
toxic foreign compounds enhance the free radical production in cells. The generation of 
reactive free radicals overwhelms the antioxidant defences in the liver and results in the 
oxidative destruction of cellular membranes and serious tissue damage. In many cases, 
the free radical production may be secondary to the initial toxic mechanism, a 
consequence rather than the cause of cell damage. 
Free Radical Induced DNA Damage 
Oxidative DNA damage from active oxygen species has been hypothesized to play 
a critical role in several diverse biological processes including mutagenesis, aging, 
carcinogenesis, radiation induced damage, and cancer chemotherapy (Ames, 1983; 
Cerutti, 1985; von Sonntag, 1987; Ames and Gold, 1991; Retel et al., 1993). These 
pathological conditions are believed to develop due to reactive oxygen species (ROS), 
namely the superoxide radicals, singlet oxygen and the hydroxyl radical arising through 
normal cellular oxidative process, inflammatory events, ischemia and xenobiotic 
metabolism (Klebanoff, 1980; Fridovich, 1983). It is now widely held that the mutagenic 
capacity of oxygen is due to the direct interaction of hydroxyl radicals with DNA. 
Hydroxyl radicals have been detected with electron paramagnetic resonance spectroscopy 
under conditions of active oxygen-induced DNA damage (Inoue and Kawanishi, 1987). 
Much evidence indicates that DNA damaging hydroxyl radicals are produced through the 
interaction of hydrogen peroxide and superoxide with transition metals. For example, 
hydrogen peroxide and superoxide do not directly interact with DNA to produce 
oxidative lesions in vitro (Breimer, 1990). Additionally, metal chelators that block the 
elaboration of hydroxyl radicals can inhibit DNA damage, mutations, and malignant 
transformation induced by active oxygen species in cell-free and cellular systems, as can 
agents that detoxify hydroxyl radicals or its precursors (Lesko et al., 1980; Brawn and 
Fridovich, 1981; Aruoma et al., 1989; Nassi-Calo et al., 1989). The carcinogenic iron 
complex nitrilotriacetic acid facilitates hydroxyl radical production from oxidants and can 
enhance oxidative DNA damage (Hartwig and Schlepegrell, 1995). Iron and copper ions 
can also promote DNA damage by active oxygen species in vitro (Aruoma et al., 
1991). An unstable radical like the hydroxyl radical will interact indiscriminately with all 
components of the DNA molecule, producing a broad spectrum of DNA damage that 
includes DNA modification of all bases as well as the production of base-free sites, 
deletions, frame shifts, strand breaks, DNA-protein cross links, and chromosomal 
rearrangements (Halliwel! and Aruoma, 1991). In particular, endonucleases activated 
through an oxidant-stimulated rise in intracellular calcium can stimulate the formation of 
strand breaks and degradation products of the DNA molecule (Nicotera et al., 1990). 
Hydroxylation of Guanine Bases 
The apparently most abundant and certainly the most studied oxidative modification 
of DNA bases involves the C-8 hydroxylation of guanine, frequently estimated as the 
oxidize deoxynucleoside, 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-G) (Floyd et al., 
1986; Shigenaga et al., 1989; Floyd, 1990; Dizdaroglu, 1991; Inoue and Kawanishi, 
1995). The pulse radiolysis of 2'-deoxyguanosine (dG) and its 5'-monophosphate 
(dGMP) in the presence of oxidizing and reducing agents, showed the hydroxyl radical 
addition to C-4, 5, and 8 of guanine, giving the radicals G4*OH, G5'OH, and G8'OH 
(Fig. 1). The hydroxyl radical adducts of guanine undergo redox ambivalence. The 
7 
<> . <> I) 
UN' 
R ' H O R R 
Guanine G4&H GSOII 
» o G80H o 
KJ 
OH I^
NV-O\o£lg HN^yOoH HN-*SfN O, 
V \ * „,N^NW« ~ ^J^-i 
HN 
R "2" ^ R 
oxidizing reducing 
U e . + H* U c - . + H* I -e".-H\or 
• t J + O J . - O J - . - H * 
°
 u 0 1 H rin | H ° 
\ N ^ ° „«»S , HN^V-NTbH HN^yN 
*N^NH U . M ^ M > - N H , . . . X . X M ' 
HN __ ...,
 W I I 
H 2 N ^  H 2 N ^ N ^  H ^ * 
R 2 R 
H 2 N ^ N ^ N 
R 
FAPyG 8-OH-G 
R = DNA sugar 
Fig. 1. Products formed by the action of h y d r o x y ! radical on guanine. 
8 
reduction of G8*OH yields ring opened product 2,6-diamino-4-hydroxy-5-
formamidopyrimidine (FAPy) compound (Dizdaroglu, 1991). Later studies found that 
FAPy is formed in DNA (Fuciarelli et al, 1990) and chromatin (Gajewski et al, 
1990) in human cells (Nackerdien et al, 1992), and in mice livers after whole body 
irradiation (Mori et al., 1993). The oxidation of G8'OH, rearomatized the imidazole ring 
giving 8-hydroxyguanine (8-OH-G) or 7,8-dihydro-8-oxo-guanine (8-oxo-G) isolated from 
irradiated DNA (Kasai et al., 1984; Dizdaroglu, 1985; Fuciarelli et al., 1990), 
chromatin (Gajewski et al., 1990), human cells (Nackerdien et al., 1992; Kasai et al., 
1986) and mice liver (Mori et al., 1993). In particular, NMR studies of the 
tautomerism of 8-OH-G indicate that the oxygen at the C-8 position is most likely to 
adopt the keto form at physiological pH. Further, in contrast its normal counterpart, the 
oxidized base assumes the syn conformation about the glycosyl bond in DNA (Cho et 
al., 1990). Both these structural considerations impact the base-pairing properties of the 
oxidised base. NMR structural analysis have demonstrated the 8-oxo-G (syn) will form 
a stable base pair with A (anti) in the interior of the DNA helix without perturbation of 
flanking base pairs (Kouchakdjian et al., 1991). Figure 2 shows the structure and base 
pairing of guanine, the formation of its oxidized product, 8-oxo-G, and the abnormal 
base pair 8-oxo-G form in DNA. The mutation resulting from this 8-oxo-G-A mispairing 
will lead to G—>T transversion (Shibutani et al, 1991; Cheng et al, 1992). 8-OH-G 
is considered to be an excellent marker of oxidative DNA damage (Wood et al, 
1990; Shibutani et al, 1991; Lunec et al, 1994; Tritscher et al, 1996) due to its 
highly mutagenic potential (Kuchino et al, 1987; Ames and Gold, 1991; Kasai and 
Nishimura, 1991; Guyton and Kensler, 1993 ; Moriya and Grollman, 1993; Musarrat 
and Wani, 1994). 
Other abundant oxidatively modified purines and pyrimidines include, 8-oxo-adenine, 
2-hydroxy adenine, FAPy adenine, 5-hydroxy methyl uracil, 5-hydroxy cytosine, cytosine 
glycol and thymine glycol (Tg). In addition, a large number of other modifications of 
bases and sugars have been identified (Dizdaroglu, 1991; 1994). The yield of the 
individual DNA modifications is highly dependent on which reactive oxygen species are 
involved. Thus, whereas singlet oxygen induces preferentially 8-oxo-G (Epe, 1991), 
superoxide has low reactivity (Fischer-Nielsen et al, 1994), and hydroxyl radical can 
cause almost any modification (Dizdaroglu, 1991). 
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Repair of Oxidative DNA Damage 
DNA repair systems are the key lines of defense that prevent or limit the 
biological effects of DNA damage. It comprises of a variety of enzymes that excises the 
modified bases and deoxyribose sugar and the strand breaks are annealed (Ramotar and 
Demple, 1993; Demple and Harrison, 1994). The repair products are excreted into the 
urine. DNA glycosylases excise bases and subsequently endonucleases incise the 
phosphodiester bonds on each site of abasic sites allowing insertion of an intact 
nucleotide. Endonuclease III possesses both glycosylase and endonuclease activities for 
repair of oxidized pyrimidines. The formamidopyrimidine-DNA glycosylase enzyme (Fpg; 
mutM) in E. coli repairs 8-oxo-dG and 2,6-diamino-4-hydroxy-5-formamidopyrimidine 
and to a lesser extent the corresponding adenine derivatives by base excision (Boiteux 
et al., 1992). Exonucleases incise the apurinic site for insertion of a new nucleotide. In 
humans, similar two step pathways yielding 8-oxo-G have been identified in addition to 
repair of 8-oxo-dG by single step excision of the complete nucleotide (Bessho et al., 
1993). In E. coli the mutM and mutT repair enzymes cooperate functionally with mutY, 
an enzyme which removes adenine misinserted opposite 8-oxo-G in DNA (Tajiri et al., 
1995). Lack of DNA repair mechanisms would lead to have increased mutation 
frequencies in the early steps of carcinogenesis (Freidberg, 1985). 
Antioxidants 
Antioxidants are another key line of defense capable of scavenging free radicals by 
preventing radical formation, intercepting radicals from further activity (Cotgreave et al., 
1988), or participating in repair of damage caused by free radicals (Sies, 1993). 
Enzymatic defense systems include superoxide dismutases (SOD), which catalyzes the 
superoxide dismutation to produce H202 and 02 at 104 times higher rate than 
spontaneous dismutation at physiological pH. Catalase (CAT) mediates the detoxification 
of H202 from the cell when it is present in high concentrations. 
SOD 
2 0 / + 2H+ > H202 + 02 
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CAT 
2H202 > 2H20 + 0 2 
Selenium dependent glutathione peroxidase (GSHpx) catalyzes the reduction of H202 and 
organic free hydroperoxides requiring glutathione as substrate (Ernster, 1987). 
GSHpx 
H202 + 2GSH > GSSG + 2H20 
GSHpx 
ROOH + 2GSH > GSSG + ROH + H20 
Glutathione reductase reduces oxidized glutathione utilizing NADPH generated by various 
systems 
GSSG + NADPH + H+ > 2GSH + NADP+ 
Other enzymatic proteins such as DT-diaphorase or epoxide hydrolase are also 
considered to be primary antioxidant defenses (Ernster, 1987; Lind et al., 1990). 
Transferrin or lactoferrin and ferritin reduce the free iron ion concentration, 
preventing hydroxyl radical generation through the Fenton-type reactions (Halliwell and 
Gutteridge, 1984; 1985; Thurnham, 1990). Albumin and ceruloplasmin transport copper 
in plasma, but the later does not prevent interaction between this metal and superoxide 
or hydrogen peroxide to generate hydroxyl radical (Thurnham, 1990; Meucci et al., 
1991). Glutathione (GSH), vitamin C, uric acid, taurine and hypotaurine are some of the 
small molecules widely distributed in biological systems, scavenge oxygen free radicals 
non-enzymatically. Vitamin E (a-tocopherol), the major lipid-soluble antioxidant protects 
against lipid peroxidation by donating a hydrogen ion to oxygen free radical. The 
resultant tocopheryl radical may be reduced by the ascorbic acid-GSH redox couple 
(Cadenas, 1989; Empey et al., 1992). P-carotene, the most efficient scavanger of 
singlet oxygen, has a synergistic action with vitamin E (Machlin and Bendich, 1987; 
Bendich and Olson, 1989; Di Mascio et al., 1991) Finally, bilirubin breaks the chain 
of damage propagation by reacting with the oxygen free radicals which cause this 
damage (Cotgreave et al., 1988; Stocker et al., 1990). 
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Autoimmunity and Autoimmune Diseases 
Immune mechanisms are not always protective or beneficial to the host. Under 
certain conditions, immunological disbalance results in discriminating between 'self and 
'non-self leading to antibody production against various cellular components and tissue 
injury, resulting in clinical disease. Thus, autoimmune diseases are those which result 
from immunologic reactions, humoral and/or cellular, directed against the individual's own 
tissue components, leading to clinical disease (Deodhar, 1992). An autoimmune disease 
may be organ/tissue specific, for example, Hashimoto's syndrome, thyrotoxicosis, 
pernicious anaemia or non-organ/tissue specific (systemic) such as progressive systemic 
sclerosis (PSS) or systemic lupus erythematosus (SLE). There is no single theory or 
mechanism that can adequately explain all features of autoimmune diseases. However, 
three models have been proposed for the induction of a productive autoimmune 
process. The first is the autoimmune response to a cross-reacting antigen, i.e., 
crossreactivity between host and foreign antigens or modification of host proteins due to 
infection, drug administration, inflammation etc. (Theofilopoulos and Dixon, 1985; Huang 
et al, 1988). The second is a genetic predisposition for autoimmunity through regulatory 
failure, and the third is the triggering with bacterial mitogen of potentially autoimmune B 
cells, normally held in check by suppressor cells. Perhaps the best approach, as 
suggested by Shoenfeld and Isenberg (1989), is to consider the wide spectrum of 
autoimmune diseases as the "mosaic" of autoimmunity with its many pieces, genetic, 
hormonal, immunological, and environmental, leading to diverse diseases. 
Autoimmune diseases show a highly significant familial predisposition (Hochberg, 
1987; Arnett, 1992). The involvement of genetic factors has been linked to the human 
lymphocyte antigen (HLA) system, particularly the HLA-DR sublocus. The HLA genes 
functions as secondary genes to allow expression of specific autoantibody or the 
respective disease state (Bias et al., 1986). The initiation of an autoimmune response 
requires that the self-reactive T cells interact with self-antigen and HLA class II antigen 
complex with sufficient avidity for the development of autoantibody in subsequent 
autoimmune diseases. The association between certain autoimmune diseases and HLA 
antigens (Braun and Zachary, 1988) such as SLE DR2 and DR3, Sjogren's syndrome 
and DR2 and for DR3, insulin-dependent diabetes mellitus or diabetes Type I DR4 and 
13 
DR3, Grave's disease and DR3, myasthenia gravis and DR3, rheumatoid arthritis and 
DR4 are well documented. 
In a wide variety of autoimmune diseases, the regulatory failure results in 
significant decrease in T-suppressor cell numbers and activity, thereby imbalancing the T-
helper/T-suppressor cell ratio. The increased T-helper/T-suppressor cell ratio has been 
noted in a wide variety of autoimmune diseases, such as, SLE, Sjogren's syndrome, 
PSS or scleroderma, rheumatoid arthritis, pernicious anemia, multiple sclerosis, immune 
complex-mediated renal diseases, immunologic skin diseases and many others. It is well 
established that the human immunodeficiency virus (HIV) associated immune dysregulation 
results in autoimmune phenomena or inversely some type of autoimmune mechanism may 
contribute to the immunopathogenesis of the HIV infection itself (Calabrese, 1988). The 
autoantibodies associated with HIV infection include antinuclear antibodies, rheumatoid 
factor, anti-cardiolipin antibodies, anti-platelet, anti-red cell and anti-lymphocyte 
antibodies. Other viral agents involved in initiating autoimmune phenomena include 
hepatitis B infection associated with chronic active hepatitis and polyarthritis nodosa, EB 
virus in polymyositis, HTLV-1 virus in multiple sclerosis, and related neurologic diseases 
(Weetman and Borysiewicz, 1990). Hormonal factors such as sex hormones, thymic 
hormones and corticosteroids play a significant role so that autoimmune disease occur 
predominantly in females than males (Talal, 1989; Counihan et al., 1991; Lahita, 1992; 
Moinuddin and Ali, 1994). It has been reported that testosterone and thymic hormones 
enhance CD8+ T-cell receptor function (Lahita and Kunkel, 1984), whereas estrogen 
may suppress this function (Talal and Ahmad, 1987). 
Immunological crossreactivity and molecular mimicry has been an important 
phenomena in autoimmune diseases. It has been suggested that the degree of sequence 
conservation between host and a given infectious agent, heat shock proteins, because of 
molecular mimicry, may provide the link between infection and subsequent autoimmunity. 
In responding to the virus, the immune system may become activated to attack the self 
molecule, since only a few residues are needed to stimulate the immune response. For 
example, adenovirus type II has sequences very much like those of myelin basic protein 
(Steinman, 1993). The reason that some persons may mount an immune response against 
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self and others do not may be because HLA molecules from different individuals display 
different portions of the antigen to T cells. Thus, one person's HLA molecule may bind 
a self-mimicking portion while another's may not. Antibodies to cardiolipin have been 
shown to cross-react with DNA, thus suggesting the possibility that in SLE, native 
DNA may not be the initiatingfactor for autoimmune reactivity, rather, the pathogenic 
anti-DNA antibody may be an example of immunologic crossreactivity (Nakamura and 
Binder, 1988; Arif et al., 1994). 
Polyclonal B cell activation has been proposed as one possible mechanism that 
may be responsible for the over-activation of B cells and production of autoantibodies 
in certain autoimmune diseases, particularly SLE (Dziarski, 1988; Klinman et al., 1990; 
Steinberg, 1992). In autoimmune prone individuals, B cells are hyper-responsive to 
polyclonal activators and undergo initial activation, followed by expansion of autoreactive 
clones, under the influence of exogeneous or endogeneous polyclonal activators. Various 
polyclonal B-cell activators such as Epstein Barr Virus (EBV) and its components, and 
endotoxin or lipopolysaccharide (LPS), certain bacterial agents and drugs may function 
by bypassing T cell regulatory mechanisms and activating B cells directly. 
The 'modified self hypothesis suggests that autoimmunity may arise as a result of 
an immune response against modified self determinants (neo-self determinants) such as 
new determinants created on somatically mutated antibodies during the maturation of the 
immune response. Although natural anti-idiotypic autoantibodies have been detected, it is 
thought that such idiotypic determinants generally do not reach an adequate level to 
induce pathogenic immune responses. Rheumatoid factors (RFs), which are anti-IgG Fc 
autoantibodies induced transiently during an immune response, presumably because neo-
antigenic determinants are exposed on antigen-complexed IgG. Glycosylation defects in 
IgGs have also been proposed as playing a role in RF induction, although the specificity 
of this phenomenon is uncertain (Tsuchiya et al., 1993). "Nephritic factor" referring to 
an autoantibody against neoantigenic determinants reveals the complement protein C3 
during complement activation (Spitzer et al., 1992). Other possibilities for creation of 
neo-self determinants occur through binding of drugs or other haptenic groups to self-
molecules, as well as through molecular modifications introduced, for example, by gene 
mutations. A long list of drugs has been compiled, all of which may be correlated with 
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SLE-like symptoms, but the mechanisms for these adverse effects remain unknown. 
Some investigations suggest binding to MHC with subsequent induction of alloreactivity, 
whereas others suggest interference with gene methylation (Quddus et al, 1993). 
Further investigation of the mechanisms by which environmental or iatrogenic chemical 
compound induced autoimmunity is highly warranted. 
Systemic Lupus Erythematosus 
Systemic lupus erythematosus is a multisystem, inflammatory disorder characterized 
by the production of autoantibodies of multiple specificities, especially antibodies reactive 
with nuclear ligands, including native DNA (Andrews et al, 1978; Smith and Steinberg, 
1983; Tan, 1985; Steinberg et al, 1990; 1991; Steinberg, 1992; Harada et al, 1994). 
One of the impediments to understanding human systemic lupus has been its marked 
heterogeneity (Steinberg et al., 1991; Steinberg, 1992). Indeed, a comparable 
heterogeneity is observed among the several strains of mice which spontaneously develop 
SLE-like syndromes. Taken together, they demonstrate the genetic and pathogenetic 
heterogeneity of lupus (Ebling and Hahn, 1980; Theofilopoulous and Dixon, 1980; 
Steinberg et al, 1984). 
From the last 40 years, anti-DNA antibodies were identified and linked to patients 
with SLE. The clinical manifestations include fever, an erythematous 'butterfly' rash 
across the face, lesions of discoid lupus or a vasculitic rash, polyarthralgia and arthritis, 
polyserositis (especially pleurisy and pericarditis), anemia, thrombocytopenia, renal, 
neurologic, and cardiac abnormalities. SLE, a common disease with a strong female 
preponderance with female/male ratio of 9:1. Although the cause of SLE remains 
obscure, current concepts suggest that, this is a multifactorial disorder in which there is 
profound disturbance of immune regulation. A defect of suppressor T lymphocytes is 
associated with polyclonal B cell activation and the uncontrolled production of 
autoantibodies and circulating immune complexes. 
The immunological abnormalities found in SLE are given in Table 1. Antinuclear 
antibodies can be detected by indirect immunofluorescence in the serum of more than 
90% of patients. Radioimmunoassays are more specific for antibodies to undenatured 
16 
TABLE 1 
Immunological Abnormalities Detectable in the Blood of 
Patients with SLE 
Anti-nuclear antibodies 
Anti-DNA-histone (and LE cells) 
Anti-DNA (single and double stranded) 
Anti-RNA 
Anti-Sm 
Anti-UIRNP 
Anti-Ro/SS-A 
Anti-La/SS-B 
Anti-MA 
Anti-PCNA 
Depression of CH50 and C3 and C4 
Antibodies againsterythrocytes, leucocytesand platelets 
Antineuronal antibodies 
Biological false positive tests for syphilis 
Circulating anticoagulants (anti-cardiolipin antibodies) 
Anti-thyroid (and other organ specific autoantibodies) 
Rheumatoid factors 
Cryoglobulins 
Circulating immune complexes 
Sm, Ro, La, MA - antibodies identified by initials of patients in whom they were discovered 
CH50 - Total haemolytic complement activity 
C3, C4 - Complement components 
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double stranded DNA (Takeuchi et al., 1997). High levels of anti-DNA antibodies 
coupled with depressed total haemolytic complements (CH50) activity (Nishiya and 
Hashimoto, 1997) and low C3 and C4 complement component suggest that there is 
activation of the classical complement pathway in active immune complex disease. 
Further evidence for circulating immune complexes may be obtained by finding a 
cryoprecipitate or by using one of a number of tests for Clq binding. Tissue evidence 
for immune complex deposition comes from detecting complement components and 
immunoglobulins by immunofluorescence at the dermo-epidermal junction skin (lupus 
'band' test) or in organ biopsies. 
Lupus anticoagulant activity is detected by prolongation of the partial thromboplastin 
time (PTTK, APTT) which is not correctable by the addition of normal plasma or by a 
prolongation of the dilute prothrombin time. Anticardiolipin antibodies are detected by 
ELISA (Verthelyi and Ansar, 1997). High titers are associated with thrombocytopenia, 
thrombotic manifestations, pulmonary hypertension and neurologic problems such as 
chorea, strokes or TIAs and in some cases recurrent abortion (the anti-phospholipid 
syndrome). 
Historically, lupus is considered to be the prototype of a spontaneous immune 
complex disease in which anti-DNA antibody-DNA deposit in the tissues and induce 
inflammation. Although anti-double stranded DNA antibodies are considered to be the 
hallmarks of human lupus nephritis (van Bruggen et al., 1996), most of the anti-DNA 
antibodies in the murine renal lesions also bind to single stranded DNA (Theofilopoulos 
and Dixon, 1985; Gavalchin and Dutta, 1987). Recently, the interaction of nucleosome/ 
antibody complexes bound to heparan sulphate in the kidney, for the initiation of 
nephritis have been reported (Naparstek and Madaio, 1997). A novel subset of murine 
monoclonal anti-DNA antibodies that deposit in cells and cross both cellular and nuclear 
membranes to deposit in nuclei in vivo have been described. (Foster et al., 1994; 
Kieber-Emmons et al., 1994; Yanase et al., 1994). Another monoclonal anti-DNA 
antibody, termed 3E10, bave been reported to penetrate murine renal tubular cells and 
localizes in the nucleus. 
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Several genetic and environmental factors play important roles in assessing the role 
of anti-DNA antibodies (Isenberg, 1997; Schwartz, 1997). Polyoma T antigen binds with 
high avidity to mammalian DNA and the complex can be an immunogen in individuals 
with a genetic susceptibility to SLE (Rekvig et al., 1995). The complexes consisting of 
DNA and a variety of microbial DNA binding peptides inducing anti-DNA antibodies 
have been suggested (Schwartz, 1997). Undigested DNA, DNA-protein or DNA-peptide 
complexes might accumulate in lupus due to a failure to phagocytose the detritus of 
apoptotic cells and provide a source of lupus provoking immunogens (Schwartz, 1997). 
Pathogenic anti-DNA antibodies might be originated from bacterial antigens and DNA 
(Kalden and Marion, 1997). Nevertheless, a randomly encountered environmental 
stimulus is a tantalising explanation for the observation of pathogenic anti-DNA 
antibodies in one identical twin with SLE, and autoantibodies but no disease in the 
other twin. 
Autoantibodies and B cells have been in the lupus limelight for decades, but now 
T cells have been studied extensively in SLE (Spronk et al., 1996). T cells have been 
cloned from lupus-prone mice, and stimulate the production of anti-DNA antibodies and 
renal lesions when injected in vivo. In mice and humans with lupus, the histone/DNA-
binding T cells are activated, express the CD40 ligand, and have the potential to trigger 
B cells to produce antibodies. A finding that T cells from MRL-lpr/lpr mice recognise 
DNA-binding peptide from a parasite underlines the relevance of Rekvig's report 
implicating a viral DNA-binding protein (the polyoma T antigen) in human SLE. Perhaps 
many different DNA-binding peptides of microbial origin can be immunological carriers of 
nucleic acid or polynucleotide haptens. It is possible that the lupus patients collective 
experience with microbial DNA-binding proteins builds up a repertoire of carrier-specific 
memory T cells, members of which participate in triggering, enhancing, or modifying the 
activation of B cells with the capacity to produce anti-DNA antibodies. 
ROS in SLE 
DNA damage by ROS has been found in the development of autoimmune diseases, 
such as SLE (Blount et al., 1991). The process may involve the release of ROS 
intermediates from activated phagocytic cells, their passage through cell membranes, and 
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finally reaction with nuclear DNA (Bashir et al., 1993) producing altered DNA, 
stimulating DNA-antibody production. The development of autoantibodies in SLE has 
been supported by the enhanced reactivity of SLE anti-DNA antibodies to ROS-
modified DNA and polynucleotides (Blount et al., 1989; 1990; Alam et al, 1993; Ara 
and Ali, 1993; Ahmad et al., 1997; Cooke et al., 1997; ). ROS modification exposes 
base residues in the DNA backbone and minor regions of single stranded DNA (Blount 
et al., 1994), rendering DNA immunogenic. The detection of 8-oxo-dG in the immune 
complex derived DNA of SLE (Lunec et al., 1994) reinforces the evidence that ROS 
may be involved in SLE. ROS-modified DNA may therefore, play a significant role in 
the generation of immune complexes which are of recognised importance in the 
pathogenesis of SLE (Lisitsyna et al, 1996; Cooke et al., 1997). 
Progressive Systemic Sclerosis 
Progressive systemic sclerosis (PSS), also known as scleroderma is a generalized 
disorder of connective tissue characterized by inflammatory, fibrotic, and degenerative 
changes, accompanied by vascular lesions, in the skin (scleroderma), synovium, and 
certain internal organs, notably the esophagus, intestinal tract (Ebert et al., 1997), 
heart, lung and kidney (Medsger, 1985). The disease is highly variable in its 
presentation. At one end of the spectrum are patients with limited scleroderma, in whom 
skin thickening is relatively restricted to the fingers, hands, and/or face, and in whom 
internal organs compromise is delayed, often for several decades or more. Patients with 
these symptoms occur predominantly in the CREST variant of PSS i.e., a combination 
of subcutaneous calcinosis, Raynaud's phenomenon (RP), esophageal dysmotility, 
sclerodactyly, and telangiectasia (Winterbauer, 1964; Rodnan et al., 1979; Drosos et 
al., 1991). At the other end, are patients with diffuse scleroderma (Steen et al., 1980) 
in whom skin changes are wide-spread and often rapidly progressive, involving distal 
and proximal extremities and the trunk, and in whom visceral complications lead to 
cardiac failure, fulminant hypertensive renal disease, pulmonary complications, or intestinal 
malabsorption and cachexia (D'Angelo et al., 1969; Rodnan, 1972) 
The origin of PSS is obscure. PSS has been linked with rheumatoid arthritis, 
systemic lupus erythematosus, and certain other rheumatic diseases because these 
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conditions have a number of clinical features in common and because they are all 
characterized anatomically by generalized alterations of (or in) the connective tissue 
(Tsankov et al, 1990). A number of patients with scleroderma present certain clinical 
and serologic features highly suggestive of SLE (mixed connective tissue disease or 
overlap syndrome), including fever, discoid rash, pleurisy, pericarditis, lymphadenopathy, 
anemia, leukopenia, marked hypergammaglobulinemia, and positive LE cell reactions 
(Dubois et al, 1971; Sharp et al, 1972; Schneider, 1993). Like rheumatoid arthritis 
and systemic lupus erythematosus, PSS has been associated in a number of instances 
with Sjogren's syndrome and less often with Hashimoto's thyroiditis (Yazawa et al, 
1997). The serologic abnormalities has given rise to suspicion that aberrant immunity 
may play an important role in pathogenesis (Rodnan, 1972). Inflammatory manifestations, 
e.g., arthritis and myositis as well as the expression of anti-nuclear antibodies that mark 
particular disease patterns suggest a role for autoimmunity in PSS (Yuan and Chen, 
1991). Thus autoantibodies to an entirely different set of cellular antigens are observed 
in scleroderma (Table 2). Antibodies to SC1-70 occur in patients with the diffuse pattern 
of disease and bind to the enzyme DNA topoisomerase I (Nakamura and Tan, 1978; 
Shero et al, 1986; Gruschwitz et al., 1993; Vazquez-Abad et al., 1997). This enzyme 
is a 100 kd protein in its native form and can relax supercoiled DNA; the 70 kd 
antigen routinely detected is a degradation product. In the CREST variant of PSS, 
antibodies to centromere antigens (kinetochore) are the serologic hallmark (Moroi et al, 
1980; Vazquez-Abad et al., 1997). These antigens have been identified as 17kd, 80kd 
and 140kd proteins. Anti-centromere antibodies occurring frequently in CREST patients, 
do not usually coexist with antibodies to SC1-70 (Earnshaw et al., 1986; Shero et al., 
1986; Earnshaw et al., 1987; Weiner et al, 1988; Fritzler, 1997). 
Some patients of scleroderma produce autoantibodies which target intranucleolar 
antigens. These include RNA polymerase I, a complex of subunit proteins ranging from 
210 to 11 kd. Microinjection of IgG autoantibody into the frog oocyte effectively 
inhibited synthesis of 28 and 18 S ribosomal RNA (Reimer et al., 1987). A second 
"nucleolar" antigen is PM-SC1 (Polymyositis-scleroderma overlap), a complex of 11 
polypeptides ranging from 110 to 20 kd (Reimer et al, 1986; Yuan and Chen, 1991). 
The third nucleolar antigen is fibrillarin, a 34 kd protein rich in dimethyl arginine and 
21 
TABLE 2 
Nature of Autoantigens and Prevalence of Autoantibodies in 
Progressive Systemic Sclerosis 
Designation of 
autoantigen 
Prevalence(%) of 
autoantibody 
Molecular 
characteristics 
SC1-70* 70% in diffuse 
scleroderma 
Protein 70kd-degradation 
product of 100 kd DNA 
topoisomerase 
Centromere 
kinetochore" 
80% in CREST Proteins 17, 80, and 140 
kd of kinetochore 
RNA polymerase P Proteins 210 to 11 kd 
subunits of RNA pol I 
PM-SC1 
Fibrillarina 
3 
8 
Proteins 110 to 20 kd 
Proteins 34 kd complexed 
with U3RNA 
To Rare Protein complexed with 7-
2 and 8-2 RNA 
Alu-RNA-protein Rare Protein 68 kd complexed 
with Alu RNA 
Nuclear lamins Rare Proteins 70 and 60 kd 
'Antibodies highly specific for systemic sclerosis group including diffuse scleroderma and 
CREST 
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glycine. Other autoantibodies have been detected infrequently and the antigenic targets 
are 7-2 and 8-2 RNAs, a 68 kd protein complexed with Alu RNA and nuclear lamin 
proteins (Mckeon et al., 1983; Reddy et al., 1983; Kole et al., 1985). 
Autoantibodies of one specificity or another of those described in Table 2 are 
detected in 90% of all patients with scleroderma and this places the disease squarely 
among lupus, MCTD, and Sjogren's syndrome where autoantibodies have been detected 
in nearly all patients. However, other features commonly associated with immune hyper-
responsiveness such as hypergammaglobulinemia, complement activation, and abnormal T 
and B cell functions have not been consistently observed. Although the immune response 
in scleroderma is fairly diverse, it appears that patients do not produce autoantibodies to 
several antigens simultaneously as they do in lupus. 
Structure of Polyguanylic Acid 
The synthetic polynucleotides are of considerable interest because of their close 
relation to the naturally occurring nucleic acids. Both the natural and synthetic polymers 
are often capable of assuming more than one configuration, and a great deal of 
attention has been focussed on these structural changes. All these molecules can be 
found in an amorphous, random coil form in which there is no regular regulation 
between the orientation of succesive nucleotides among the polymer chain. In a suitable 
environment, many polynucleotides are also capable of forming elongated, helical 
molecules in successive groups have a fixed position relative to each other. 
A number of homopolyribonucleotide structures have been investigated by the 
techniques of X-ray fibre diffraction. The results established the close structural similarity 
between poly(I) and poly(G) and provides one of the principal arguments that their 
structure is four-stranded (Zimmerman et al., 1975; Simard and Savoie, 1994). High 
stability of ordered poly(G) has been observed by many investigators using a variety of 
physical methods (Fresco and Massoulie, 1963; Lipsett, 1964; Miles and Frazier, 1964; 
Pochon and Michelson, 1965; Englander et al., 1972). The I.R. spectroscopy shows 
the existence of metastable and stable ordered, multistranded forms of poly(G) (Howard 
et al., 1977). One form is inverted spontaneously and irreversibly to the other, but 
can be regenerated by freezing and thawing of solution. The high charge density of 
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four-stranded poly(G) makes it especially susceptible to electrostatic destabilization by 
the use of tetraethylammonium counterions, which screen electrostatic repulsion of 
multiple strands less effectively than alkali metal ions and significantly lower the transition 
temperature of the helix. Zimmerman et al. (1975) proposed a structure of poly(G) in 
which four guanine residues are mutually hydrogen bonded N(1)H to (6)0 and N(2)H 
to N(7) in a closed planar array. The plane of the four bases is perpendicular to the 
axis of the four stranded helix, and the ribose residues are in the C(3')-endo 
conformation. A slightly different structure was proposed by Arnott et al. (1974) in 
which the plane of the bases is tipped by 8.9° relative to the helix axis, and the 
ribose conformation is C(2')-endo. Evidence for G-G hydrogen bonding and stacking 
comes from the IR spectra and from NMR data (Pinnavaia et al., 1975; Saenger, 
1984) on the similar helical self structure formed by 5'-GMP in neutral or slightly basic 
solution. High stability of poly(G) is favoured in the tetrameric bonding scheme by 
formation of two hydrogen bonds per base (Zimmerman et al., 1975). A search for 
other possible modes of G-G association in neutral solution suggested that none was 
likely to be as stable as the tetrameric arrangement (Hattori et al., 1975a). Guanine is 
unique in the naturally occurring bases in having a pair of hydrogen bond donors and a 
pair of hydrogen bond acceptors arranged approximately at right angles to each other. 
This permits the formation of a planar square array with two hydrogen bonds per base, 
compared with 1.5 bonds per base, in the G.C pair of DNA. This additional hydrogen 
bond significantly stabilize the ordered polynucleotide helices (Howard et al., 1966a and 
b; Ikeda et al., 1970) and enhance the thermal stability of poly(G) besides involving 
other factors as hydrophobic bonding and the van der Waal's interactions. Evidence on 
the stabilizing effect of hydrogen bonds has been provided in a variety of synthetic 
polynucleotides (Howard et al., 1966a; Ikeda et al., 1970; Hattori et al., 1975a and 
b; Howard et al., 1976). Dimethylsulphoxide is an effective denaturant for nucleic acids 
(Strauss et al., 1968; Englander et al., 1972), and 90% dimethylsulphoxide is evidently 
capable of completely destabilizing the ordered form of poly(G) if sodium ion 
concentration is quite low. In 50% dimethylsulphoxide, poly(G) exists in an ordered 
form at ambient temperature but can be melted by heating. 
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Antibodies to RNA 
Reactions of SLE sera with ribosomes (Sturgill and Carpenter, 1965; Schur et al, 
1967) and ribonucleoprotein (Koffler et al, 1971; Mattioli and Reichlin, 1971) suggest 
that RNA may also serve as an antigen in this disease. Various reports showing positive 
results in several kind of assays have been obtained with SLE sera and double stranded 
polyribonucleotides, including poly(A).poly(U), poly(I).poly(C), or naturally occurring viral 
double stranded RNA (Schur and Monroe, 1969; Epstein et al., 1971; Schur et al, 
1971; Talal et al., 1971). Koffler et al. (1971) found positive passive agglutination 
reactions to occur more frequently with double stranded polyribonucleotides than with 
native DNA in diseases other than SLE. Considerable heterogeneity in antigen binding 
characteristics was observed when several polynucleotides were used as antigens. Schur 
and Monroe (1969) found that several of these sera also precipitated with the 
homopolymers poly(I), poly(A), and poly(G). In general SLE sera reacted better with 
naturally occurring double stranded RNA of viral origin than with synthetic copolymers 
(Schur et al, 1971; Talal et al., 1971). It is noteworthy that the poly(I).poly(C) 
accelerated production of both anti-double stranded RNA and anti-DNA antibodies, 
even though these are distinct antibody populations (Steinberg et al., 1969; Carpenter 
et al., 1970; Talal et al, 1971). 
H241, a murine monoclonal autoantibody binds well to native DNA and displays 
several cross reactions (Stollar et al, 1986). It reacts with higher concentrations of 
cardiolipin probably by recognizing repeated and appropriately spaced phosphates of the 
phospholipid (Lafer et al, 1981). H241 shows wide range of cross reactivity then do 
most induced anti-nucleic acid antibodies, as it combines with poly(I), poly(G), native 
DNA, denatured DNA and Z-DNA. In contrast it shows little or no reactivity with 
several single stranded homopolymers, poly(A), poly(( ), poly(U); double stranded RNA, 
poly(A).poly(U), poly(I).poly(C); DNA-RNA hybrid, poly(A).poly(dT); or triple 
stranded helices, poly(A).poly(I).poly(I) or poly(A).poly(U).poly(U). 
Poly(G) and poly(I) were the only polyribonucleotides to react with H241, 
suggesting that either the antibody recognized some feature common to these purines, 
such as 6-carbonyl and a portion of the imidazole including the 7-N, or else that the 
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polynucleotides of guanine and hypoxanthine had the appropriate spacing of phosphates 
in the backbone whereas other polyribonucleotides did not. X-ray fibre diffraction of 
poly(G) and poly(I) shows their structure to be four stranded (Zimmerman et al., 
1975), and contain its pentoses in a C(2')-endo, a conformation more characteristic of 
DNA than RNA (Arnott et al., 1974). Among the double helical 
polydeoxyribonucleotides of varying base composition, H241 exhibits a preference for 
poly(dG-dC). Stollar et al. (1986) found that H241 bound portion of guanine and 
cytosine in the major groove and the 2-amino group of a guanine in the minor groove. 
Objective of the Present Study 
Human exposure to reactive oxygen species has been implicated in the etiology of 
a number of human diseases due to formation of various modified DNA bases, most 
abundantly the 8-hydroxyguanine. In the present study, a synthetic ribohomopolymer 
[poly(G)] was modified with hydroxyl radical generated by irradiation of hydrogen 
peroxide at 253.4 nm. The modified poly(G) was characterized by UV absorption and 
CD spectroscopy and thermal denaturation studies. The strand breaks in modified 
poly(G) was detected by Sephadex G-200 gel chromatography, densitometric scanning, 
agarose gel electrophoresis and gel diffusion. In addition, ion exchange chromatography 
on DEAE Sephadex A25 column was used to quantify the guanine base modifications in 
ROS-poly(G). Both the native and ROS-poly(G) induced high titer antibodies in rabbits. 
Induced antibodies were characterized for their fine antigenic specificity with various 
nucleic acid polymer. 
In order to assess the possible role of ROS-modified epitopes in the etiology of 
inflammatory autoimmune diseases, sera from SLE and PSS patients were investigated 
for the presence of antibodies to native and modified poly(G). In addition, the frequency 
of precipitating antibodies to native and ROS-poly(G) in SLE and PSS sera were 
investigated by counterimmunoelectrophoresis. Furthermore, native and ROS-poly(G) was 
used to induce antibodies in rats which were tested for immune complex deposition in 
the kidney glomeruli by immunofluorescence. 
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MATERIALS 
Polyguanylic acid [poly(G)], and other synthetic polynucleotides, DEAE Sephadex A 
25, Protein A-Sepharose CL-4B, Sephadex G 200, agarose, Ficoll 400, xylene 
cyanole FF were purchased from Pharmacia Fine Chemicals, Sweden. Calf thymus 
DNA, buffalo thymus RNA, nuclease S,, bovine serum albumin, methylated bovine 
serum albumin, anti-human-/anti-rabbit- IgG-alkaline phosphatase conjugate, anti-rat-
IgG-HRP and FITC conjugate, p-nitrophenyl phosphate, ethidium bromide, 
Coomassie Brilliant Blue G 250 and R 250, sodium dodecyl sulphate, Tween-20, 
orcinol, Millipore filter (0.45 uM pore size), Freund's complete and incomplete 
adjuvants, were purchased from Sigma Chemical Company, U.S.A. Folin-Ciocalteau 
reagent and Blue Dextran 2000 were purchased from Centre for Biochemical 
Technology, New Delhi. 
Polystyrene microtitre flat bottom ELISA plates having 96 wells (7 mm 
diameter) were purchased from Nunc, Denmark. Acrylamide, ammonium persulphate, 
bisacrylamide, N,N,N',N'-tetramethylethylene diamine (TEMED) were from Bio-Rad 
Laboratories, U.S.A. EDTA (disodium salt), hydrogen peroxide, chloroform, isoamyl 
alcohol, methanol, glacial acetic acid were from Qualigens, India. Diphenylamine and 
ethanol were chemically pure. All other reagents/chemicals were of highest analytical 
grade available. 
Equipment 
ELISA microplate reader MR-600 (Dynatech, U.S.A.), ELISA microplate 
washer (Denley, England), Elico pH meter model Ll-120, Shimadzu UV-240 
spectrophotometer equipped with thermo-programmer and controller unit, gel scanner 
GSC-3A, ultraviolet lamp having maximum emission at 253.4 nm and UV-
transilluminator (Vilber Lourmat, France), agarose gel electrophoresis assembly 
(GNA-100) and gradient mixer GM-1 (Pharmacia, Sweden), Avanti 30 table top 
high speed centrifuge (Beckman, U.S.A.), power supply model PAC 300 and 
polyacrylamide gel electrophoresis assembly (Bio-Rad, U.S.A.), fluorescent 
microscope (Nikon, Japan) were the major equipments used in this study. 
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Serum Specimens 
Normal human sera were obtained from healthy subjects. SLE and PSS sera 
were obtained from outdoor and indoor patients of the Department of Medicine, All 
India Institute of Medical Sciences, New Delhi and J.N. Medical College Hospital, 
A.M.U., Aligarh. The SLE sera showed high titre anti-DNA antibodies and fulfilled 
the American College of Rheumatology (formerly American Rheumatism Association) 
revised criteria for the classification of SLE (Arnett et al., 1988). PSS sera fulfilled 
the American Rheumatism Association (ARA) criteria for the classification of 
definite systemic sclerosis (Masi et al., 1980). Serum samples were decomplemented 
at 56°C for 30 min and stored in aliquots at -20°C with 0.1% sodium azide 
as preservative. 
METHODS 
Determination of DNA Concentration 
DNA concentration was estimated colorimetrically by the method of Burton 
(1956) using diphenylamine reagent. 
(a) Crystallization of diphenylamine 
Diphenylamine (2 g) was dissolved in 200 ml boiling hexane. After adding 
0.5 g of activated charcoal, the hot mixture was filtered through Whatman No.l 
filter paper and the filtrate was kept overnight at 4°C and dried at room 
temperature before use. 
(b) Preparation of diphenylamine reagent 
750 mg of recrystallized diphenylamine was mixed w;th 50 ml of glacial 
acetic acid and 0.75 ml concentrated sulphuric acid. The reagent was prepared fresh 
before u e. 
(c) Procedure 
One ml of DNA sample was mixed with 1.0 ml of 1 N perchloric acid and 
incubated at 70°C for 15 min. One hundred uL of 5.43 mM acetaldehyde was 
added followed by 2.0 ml of freshly prepared diphenylamine reagent. The contents 
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were mixed and incubated at room temperature for 16-20 hr. Absorbance was read 
at 600 nm and the concentration of DNA in unknown samples was determined from 
a standard plot of calf thymus DNA purified free of RNA and proteins. 
Determination of RNA Concentration 
RNA was estimated by ferric ion catalyzed orcinol reaction (Cerriotti, 1955). 
(a) Crystallization of orcinol 
Five gm of commercial orcinol was dissolved in 100 ml boiling benzene and 
decolorized with 1 g of activated animal charcoal. The suspension was filtered 
while hot and kept at room temperature for 1 hr and at 4°C until crystallization. 
The crystals were separated by filtration and dried at room temperature. 
(b) Orcinol reagent 
(i). One hundred mg ferric chloride was dissolved in 100 ml concentrated HC1 
(ii). Six per cent (w/v) orcinol in distilled ethanol 
The reagent was prepared fresh by mixing 3.5 ml of (ii) with 100 ml of (i). 
(c) Procedure 
Two ml of RNA solution was mixed with 3 ml of orcinol reagent and placed 
in boiling water for 30 min. The tubes were chilled in ice water and absorbance 
was read at 665 nm. RNA concentrations of unknown samples were calculated from 
standard plot of buffalo thymus RNA. 
Determination of Protein Concentration 
Protein was estimated by the methods of Lowry et al. (1951) and Bradford 
(1976). 
Protein estimation by Folin's-phenol reagent 
The protein estimation by this method utilizes alkali (to keep the pH high), 
Cu2+ ions (to chelate proteins) and tartarate (to keep the Cu2+ ions in solution at 
high pH). 
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(a) Folin-Ciocalteau reagent 
The reagent was purchased from Centre for Biochemical Technology, New 
Delhi and diluted 1:4 with distilled water before use. 
(b) Alkaline copper reagent 
The components of alkaline copper reagent were prepared as follows: 
(i). Two per cent sodium carbonate in 100 mM sodium hydroxide 
(ii). 0.5 per cent copper sulphate in 1 per cent sodium potassium tartarate 
The working reagent was prepared fresh before use by mixing components (i) 
and (ii) in the ratio of 50:1. 
(c) Procedure 
To one ml of protein sample was added 5 ml of alkaline copper reagent and 
incubated for 10 min at room temperature. One ml of working Folin-Ciocalteau 
reagent was added and the tubes were read at 660 nm after 30 min. The 
concentration of protein in unknown sample was determined from a standard plot of 
bovine serum albumin. 
Protein estimation by dye-binding method 
This assay is based on colour change when Coomassie Brilliant Blue G 250 in 
acidic medium, binds strongly to protein hydrophobically and at positively charged 
groups (Bradford, 1976). In the environment of these positively charged groups, 
protonation is suppressed and a blue colour is observed (X,mix- 595 nm). 
(a) Dye preparation 
One hundred mg Coomassie Brilliant Blue G 250 was dissolved in 50 ml of 
95% ethanol and 100 ml of 85% (v/v) orthophosphoric acid was added. The 
resulting solution was diluted to a final volume of 1 litre and filtered through 
Whatman No.l filter paper to remove undissolved particles. 
(b) Protein assay 
To one ml of solutions containing 10-100 ug protein was added 5 ml of dye 
solution and contents mixed by vortexing. The absorbance was read at 595nm after 
5min against a reagent blank. 
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Purification of Calf Thymus DNA 
Commercially obtained calf thymus DNA was purified free of proteins and 
single stranded regions as described by Ali et al. (1985). DNA (2 mg/ml) was 
dissolved in O.lx SSC (15 mM sodium citrate and 150 mM sodium chloride), pH 
7.3. and then mixed with an equal volume of chloroform-isoamyl alcohol (24:1) in 
a stoppered container and shaken for 1 hr. The aqueous layer containing DNA was 
separated from the organic layer and re-extracted with chloroform-isoamyl alcohol. 
The DNA was precipitated with two volumes of cold absolute ethanol and collected 
on a glass rod. After drying in air, the DNA was dissolved in acetate buffer (30 
mM sodium acetate containing 30 mM zinc chloride), pH 5.0 and treated with 
nuclease S1 (150 units/mg DNA) at 37°C for 30 min to remove single stranded 
regions. The reaction was stopped by adding one-tenth volume of 200 mM EDTA, 
pH 8.0. The nuclease S, treated DNA was extracted twice with chloroform-isoamyl 
alcohol and finally precipitated with two volumes of cold ethanol. The precipitate 
was dissolved in phosphate-buffered saline (PBS) (10 mM sodium phosphate 
containing 150 mM sodium chloride), pH 7.4. 
Polyacrylamide Gel Electrophoresis 
Nucleic acid samples were subjected to PAGE under non-denaturing 
conditions as described by Laemmli (1970). The following stock solutions were 
prepared: 
(a) Acrylamide-bisacrylamide (30:0.8) 
Thirty gm acrylamide and 0.8 gm bisacrylamide was dissolved in distilled 
water to a final volume of 100 ml. The solution was filtered and stored at 4°C in 
an amber colored bottle. 
(b) Resolving gel buffer 
Thirty six gm Tris was dissolved in 48 ml of 1 N HC1, pH adjusted to 8.8 
and final volume made upto 100 ml with distilled water. 
(c) Stacking gel buffer 
Six gm Tris was dissolved in 40 ml distilled water, pH adjusted to 6.8 with 
1 N HC1 and final volume made upto 100 ml with distilled water. 
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(d) Electrode buffer 
The electrophoretic buffer used was TAE (40 mM Tris, 1.14 ml glacial 
acetic acid and 1 mM EDTA), pH 7.9. 
(e) Procedure 
The PAGE assembly was set up and the glass plates separated by 1.5 mm 
thick spacer were sealed with 1% agarose from the sides and bottom. The non-
denaturing gel was prepared and poured between the glass plates and allowed to 
polymerize at room temperature. Nucleic acid samples were mixed with one-tenth 
volume of 'stop mix' (30% Ficoll, 0.025% xylene cyanole FF and 500 mM 
EDTA in 10 times concentrated TAE buffer) and applied onto the gel. The gel was 
electrophoresed for 8 - 10 hr at room temperature at 80 Volts, stained with 
ethidium bromide (0.5 ug/ml) and visualized under UV light. 
Recipe for 7.5 % non-denaturing PAGE 
Acrylamide-bisacrylamide 10.0 ml 
Resolving gel buffer 5.0 ml 
1.5% Ammonium persulphate 1.5 ml 
Distilled water 23.5 ml 
TEMED 20.0 uL 
PAGE FOR PROTEINS 
A 7.5% resolving gel was layered with 2.5% stacking gel according to the 
composition given below. 
Solutions Stacking gel Resolving gel 
7.5 ml 
3.75 ml 
16.95 ml 
0.3 ml 
1.5 ml 
15.0 uL 
Acrylamide-bisacrylamide 
Stacking gel buffer 
Resolving gel buffer 
Distilled water 
10% SDS 
1.5% Ammonium persulphate 
TEMED 
2.5 
5.0 
-
11.3 
0.2 
1.0 
15.0 
ml 
ml 
ml 
ml 
ml 
uL 
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Protein samples were mixed with one-fourth volume of sample buffer (10% 
glycerol and 0.002% bromophenol blue in 10 times concentrated 0.5 M Tris HC1, 
pH 6.8) and applied onto the gel and electrophoresed at 70 Volts for 6-8 hr 
using Tris-glycine buffer (25 mM Tris, 192 mM glycine containing 1% SDS), pH 
8.3. The gels were stained overnight with 0.1% Coomassie Brilliant Blue R 250 (in 
25% isopropanol and 10% glacial acetic acid). Destaining was carried out with a 
mixture of 10% methanol and 10% glacial acetic acid. 
ROS Modification of Poly(G) 
A solution of commercially obtained synthetic RNA homopolymer polyguanylic 
acid (0.275 mM) in PBS, pH 7.4 were irradiated under 254 nm light for 1 hr at 
room temperature in the presence of hydrogen peroxide (27.5 mM). Excess of 
hydrogen peroxide was removed by extensive dialysis against PBS, pH 7.4. 
The molecular weight (M) and average length of poly(G) were calculated from the 
sedimentation coefficient (S20w= 7.8) using formula log M=2.179 (log S20+l.523) 
and found to be 183 kd and 504 nucleotides, respectively. 
Spectroscopic Analysis 
The ultraviolet spectra of native and ROS modified poly(G) were recorded 
between 200 to 400 nm on Shimadzu UV-240 spectrophotometer. 
Absorption-Temperature Scan 
Thermal denaturation analysis of nucleic acids was performed in order to 
ascertain the degree of modification incurred on the nucleic acids. Native and 
modified nucleic acid samples were subjected to heat denaturation on a Shimadzu 
UV-240 spectrophotometer coupled with a temperature programmer and controller 
assembly (Hasan and Ali, 1990). All the samples were melted from 30°C to 95°C 
at a rate of 1.5°C/min after 10 min equilibration at 30°C and the change in 
absorbance at X.max was recorded with increasing temperature. The UV spectra was 
recorded simultaneously at 30°C and 95°C in the wavelength range of 200-400 nm. 
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Circular Dichroism Measurements 
Circular dichroism (CD) measurements of native and ROS-poly(G) in PBS, 
pH 7.4 were performed in 1 nm path length cells at a constant temperature of 
25°C. The wavelengths chosen ranged from 220 nm to 350 nm. Scans were 
recorded at 0.2 nm intervals, and three spectra of each sample were recorded and 
average determined. A scan of buffer alone was recorded to adjust the base line. 
The concentration of the polymers was 0.275 mM per nucleotide. Molar ellipticities 
[0] were calculated in terms of the nucleotide concentration according to 
where, 9 is the measured ellipticity (mdeg), c is the molar concentration of 
polymer per nucleotide, and 1 is the path length in cm. 
Detection of Strand Breaks 
The damage to poly(G) mediated by hydroxyl radical was characterized by 
the presence of strand breaks. The strand breaks in poly(G) was ascertained by 
Sephadex G 200 gel chromatography, densitometric scanning, agarose gel 
electrophoresis and gel diffusion. 
(a) Sephadex G 200 Gel Chromatography 
Gel filtration was performed on Sephadex G 200 column. About 5 g of gel 
was allowed to swell in distilled water for 5 hr in a boiling water bath. The 
degassed gel slurry was poured into the column (1 x 42 cm) and left overnight at 
room temperature to settle under gravity. The flow rate was increased gradually and 
adjusted to 20 ml/hr. Uniform packing of column was checked by passing 0.2% (w/ 
v) solution of Blue Dextran 2000. The column was equilibrated with PBS, pH 7.4. 
One ml of native and ROS-poly(G) was applied onto the column. The sample 
was allowed to percolate through the upper surface of the gel and the column was 
connected to a reservoir containing equilibrating buffer. Fractions of 3 ml were 
collected and absorbance monitored at 253 nm. 
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(b) Densitometric Scanning 
Samples of native and ROS-poly(G) were mixed with stop mix without 
xylene cyanole FF, subjected to polyacrylamide gel electrophoresis on 7.5% native 
gel. The corresponding 6 cm long lanes were cut and scanned on Gel Scanner 
GSC-3A of Shimadzu UV-240 spectrophotometer. Gel was scanned at the rate of 
20 mm/min and the spectra was recorded simultaneously at a fixed wavelength of 
253 nm. 
(c) Agarose Gel Electrophoresis 
One per cent agarose in 30 ml TAE buffer (40mM Tris, 1.14 ml glacial 
acetic acid containing 1 mM EDTA) was dissolved by heating in boiling water bath. 
The solution was cooled to 50°C and poured into the gel tray and left at room 
temperature for complete solidification. One-tenth volume of stop mix dye was 
added to the sample and loaded in the wells of the submerged gel and 
electrophoresed for 2 hr at 30 mA. The gels were stained with ethidium bromide 
(0.5 ug/ml), visualized under UV light and photographed. 
(d) Gel Diffusion 
Native and ROS-poly(G) were mixed with one tenth volume of 'stop mix' 
without xylene cyanole FF and electrophoresed on 1% agarose gel for 2 hr at 30 
mA. The gel was cut into lanes and each lane was sliced into 5 mm pieces. Each 
piece was gently macerated with glass rod in 0.2 ml of 10 mM Tris HCl buffer, 
pH 8.0 containing 150 mM NaCl (Maxam and Gilbert, 1980). After overnight 
incubation at 37°C, the mixture was centrifuged at 10,000 g for 10 min. The 
supernatant containing poly(G) was filtered through Millipore filter (0.45 mu) and 
read at 253 nm. 
Separation and Quantitation of Guanine Base 
The separation and quantitation of the modified guanine base in ROS-poly(G) 
was done according to the method described by Hasan and Ali (1990). 
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(a) Acid hydrolysis of poly(G) 
Native and ROS-poly(G) were precipitated with two volumes of cold ethanol 
and dissolved in 70% perchloric acid. The samples were heated at 100°C for 1 hr 
to release the bases. The hydrolysate was neutralized and chromatographed on 
DEAE Sephadex A 25 matrix. 
(b) DEAE Sephadex A 25 column chromatography 
The swollen ion exchanger was suspended in the equilibrating buffer (1 mM 
Tris-HCl, pH 7.6) and poured in a column. The column was extensively equilibrated 
and 3 ml of sample was applied and eluted with a linear gradient of 1-20 mM 
Tris-HCl, pH 7.6 at a flow rate of 40 ml/hr. Fractions of 3 ml were collected and 
absorbance recorded at 260 nm. Elution profile of standard guanine base and 
hydrolysed native poly(G) served as controls. 
Immunization Schedule 
Native and ROS-poly(G) (50 ug/rabbit) was complexed with an equal amount 
(w/w) of methylated BSA and emulsified with an equal volume of Freund's 
complete adjuvant and injected subcutaneously at multiple sites in female rabbits 
(Hasan et al., 1991). Subsequent injections were given intramuscularly in incomplete 
adjuvant at weekly intervals. A total of 300 \xg of native and ROS-poly(G) were 
injected during the course of six injections. Animals were bled by cardiac puncture 
and serum separated, and decomplemented at 56°C for 30 min. Pre-immune serum 
was collected prior to immunization. The sera were stored in small aliquots at 
-80°C with 0.1% sodium azide as preservative. 
Isolation of Serum IgG by Protein A-Sepharose CL-4B 
Serum IgG was isolated by affinity chromatography on Protein A-Sepharose 
CL-4B column. Diluted serum (0.5 ml) with equal volume of PBS, pH 7.4 was 
applied to column (0.9 x 15 cm) equilibrated with PBS, pH 7.4. The wash through 
was recycled 2-3 times and finally the column was washed extensively with PBS to 
remove unbound material. The bound IgG was eluted with 0.58% acetic acid in 
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0.85% sodium chloride (Goding, 1978) and neutralized with 1 ml of 1 M Tris-HCl, 
pH 8.5. Three ml fractions were collected and read at 280 nm. IgG concentration 
was determined considering 1.4 O.D280 = 1.0 mg IgG/ml. The isolated IgG was 
dialyzed against PBS, pH 7.4 and stored at -20°C with 0.1% sodium azide. 
Immunological Detection of Antibodies 
Immune sera, SLE sera and PSS sera were tested for antibodies by 
immunodiffusion, counterimmunoelectrophoresis, enzyme linked immunosorbent assay 
and gel retardation assay. 
(a) Immunodiffusion 
Immunodiffusion (ID) was carried out by Ouchterlony double diffusion system 
using glass petri dishes as described by Tan et al. (1966). Six ml of 0.4% agarose 
solution in PBS, pH 7.4 was brought into molten state, allowed to cool to 50-60°C 
and subsequently poured onto 5 x 1.5 cm glass petri dishes. Wells each 5 mm in 
diameter, separated by 8 mm distance were cut onto hardened gel. Appropriate 
amount of antibody and antigen was placed in the wells and the reaction was 
allowed to proceed for 48-72 hr in a moist chamber at room temperature. The gels 
were washed with 5% sodium citrate to remove non-specific precipitin lines. The 
precipitin lines were analyzed visually and photographed. 
(b) Counterimmunoelectroph oresis 
Counterimmunoelectrophoresis (CIE) was performed as described by Kurata 
and Tan (1976) with slight modifications. Three ml of 0.6% molten agarose solution 
in 25 mM barbital buffer, pH 8.4 was poured onto microscopic slides (7.5 x 2.5 
cm) and allowed to solidify at room temperature. Wells 4 mm in diameter were cut 
at a distance of 5 mm between the two opposite wells. Antigen was placed in 
cathodal well and antibodies in the anodal well, electrophoresed for 45-60 min in 
50 mM barbital buffer, pH 8.4 with a current of 3-4 mA per slide. Non-specific 
precipitin lines were removed with 5% sodium citrate. 
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(c) Gel Retardation Assay 
Gel retardation assay was performed for the visual detection of antigen-
antibody interaction (Sanford et al., 1988). Constant amounts of nucleic acid 
samples were incubated with varying amounts of IgG in PBS, pH 7.4 for 2 hr at 
37°C and overnight at 4°C. One-tenth volume of 'stop mix' dye was added to the 
mixture and electrophoresed on 0.8% agarose for 2 hr at 30 mA in TAE buffer, 
pH 7.9. The gels were stained with ethidium bromide (0.5 ug/ml), visualized under 
UV light and photographed. 
(d) Enzyme Linked Immunosorbent Assay 
ELISA was performed using polystyrene (96 well) flat bottom microtitre 
plates as described by Aotsuka et al. (1979). 
(i) Buffers and reagents 
Tris buffered saline (TBS) 
10 mM Tris, 150 mM NaCl, pH 7.4 
Tris buffered saline-Tween 20 (TBS-T) 
20 mM Tris, 144 mM NaCl, 2.68 mM KC1, pH 7.4, containing 500 uL 
Tween 20/L 
Carbonate-bicarbonate buffer 
15 mM sodium carbonate, 35 mM sodium bicarbonate, pH 9.6, containing 
2 mM magnesium chloride 
Citrate-phosphate buffer 
22 mM citric acid, 50 mM Na2HP04, pH 5.0 
Substrates 
(i) 500 ug p-nitrophenyl phosphate (p-NPP)/ml of carbonate-bicarbonate 
buffer 
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(ii) 500 ug o-phenylenediamine (OPD)/ml of citrate-phosphate buffer, 
containing 1 ul/ml of hydrogen peroxide 
(ii) Procedure 
Polystyrene microtiter plates were coated with 100 ul of nucleic acid antigen 
(2.5 ug/ml in TBS, pH 7.4) for 2 hr at room temperature and overnight at 4°C. 
The antigen coated wells were washed three times with TBS-T to remove unbound 
antigen and unoccupied sites in test and control wells were blocked with 150 uL 
of 1.5% BSA in TBS for 4-6 hr at room temperature. The plates were washed 
with TBS-T and antibody (100 ul/well) to be tested, diluted in TBS was added to 
each well. After incubating plates for 2 hr at room temperature, the bound 
antibodies were assayed by an appropriate anti-immunoglobulin alkaline phosphatase 
or horse radish peroxidase conjugate using p-nitrophenyl phosphate or the OPD/ 
H202 substrate respectively. The plates were incubated for 1-2 hr and reaction 
stopped in the case of OPD/H202 system with 50 ul of 5 N H2S04 and read at 
490 nm. In the case of p-NPP, the absorbance was read at 410 nm. Each sample 
was coated in duplicate. Results were expressed as a mean of A - A 
r
 " test control 
Competition ELISA 
The antigenic specificity of the antibodies was determined by inhibition 
experiments (Hasan et al., 1991). Varying amounts of inhibitors (0-20 ug/ml) were 
mixed with a constant amount of antiserum or IgG. The mixture was incubated at 
room temperature for 2 hr and overnight at 4°C. The immune complex thus formed 
was coated in the wells instead of the serum. The remaining steps were the same 
as in direct binding ELISA. The results were expressed as per cent inhibition. 
Per cent inhibition = 1 ^^— x 100 
uninhibited 
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Detection of Immune Complexes Deposition in Kidney 
Kidneys from immunized rats were screened for the detection of immune 
complexes deposition in glomeruli. 
(i) Immunization protocol 
Groups of four female rats (Sprague-Dawley), were immunized subcutaneously 
at multiple sites on the back with native and ROS-poly(G) (50 ng/rat) complexed 
with methylated BSA (w/w) and emulsified in Freund's complete adjuvant. After 21 
days, three booster doses (25 ug/rat) were given intraperitoneally at weekly 
intervals with incomplete adjuvant. A group of animals were immunized similarly, 
but without any antigen, whereas another group was not immunized at all. Both 
these groups served as controls The sera were decomplemented at 56°C and 
screened for immune response by ELISA. Where necessary, another booster was 
given and finally the rats were sacrificed and kidneys stored at -80°C. 
(ii) Immunofluorescence 
Kidney were quickly frozen and sectioned in a cryostat at -30°C of thickness 
4-6 urn. Sections were fixed on slides with acetone and incubated with anti-rat IgG 
fluorescein isothiocyanate conjugate (1:10 diluted) for 30 min. Subsequently, slides 
were washed three times with PBS and mounted with 50% glycerol. The deposition 
of immune complex was detected with a fluorescent microscope. 
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Formation of ROS-poly(G) and its Characterization 
A solution of polyguanylic acid in PBS, pH 7.4 was modified with reactive 
oxygen species. UV irradiation (254 nm) in the presence of hydrogen peroxide is 
known to generate hydroxyl radical. The irradiated samples were dialyzed against 
PBS to remove excess of hydrogen peroxide. 
The UV absorption spectra was recorded on a Shimadzu UV-240 
spectrophotometer in the wavelength range from 200 nm to 400 nm. Figure 3 
shows the UV absorption spectra of poly(G) irradiated for 10, 20 and 30 min 
indicating the corresponding decrease in absorbance at 253 nm, the Xmt%. Poly(G) 
irradiated for 1 hr showed marked hypochromicity (41% decrease in absorbance) as 
compared to unirradiated poly(G) (Fig. 4a). The sample was used for further 
studies. The UV difference spectra of ROS-poly(G) with reference to native poly(G) 
exhibited negative band, having absolute peak between 234 nm to 282 nm and 
significantly increased absorbance around 300 nm (Fig. 4b). 
Native and ROS-poly(G) were mixed with poly(C) to form poly(G).poly(C) 
complexes. UV absorption spectra of poly(G) and poly(C) showed Xmax at 253 nm 
and 269 nm respectively (Fig. 5). After mixing and allowing it to anneal, the Xmi% 
shifts to 261 nm. The shift in Xmax shows the formation of poly(G).poly(C) double 
stranded complex. The UV-absorption characteristics of native and ROS-poly(G) 
complexed with poly(C) are depicted in Table 3. The absorbance ratio (A260/A280) 
was 1.82 for native poly(G) and 1.70 for ROS-poly(G). After complexing with 
poly(C), the ratio was 2.21 for poly(G).poly(C) and 1.78 for ROS-poly(G).poly(C) 
complexes. This difference in absorbance ratio could be due to some structural and 
conformational changes in poly(G) incurred after ROS modification. 
Circular Dichroism of Native and ROS-Poly(G) 
The CD spectra of the native and ROS-poly(G) was recorded in the 
wavelength range of 220 nm to 350 nm and showed characteristic changes in 
ellipticity (Fig. 6). Native poly(G) shows negative ellipticity from 222 nm to 
246 nm and positive ellipticity from 246 nm to 309 nm with an unresolved 
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Fig. 3. UV absorption spectra of native poly(G) ( ), irradiated for 10 min 
( ), 20 min ( ) and 30 min ( ) under UV light in presence of 
hydrogen peroxide. 
42 
-0.5 
400 200 
WAVELENGTH (nm) 
400 
4. (a) UV absorption spectra of native poly(G) ( ) and ROS-poIy(G) ( -) 
irradiated for 1 hr. (b) UV difference spectra of ROS-poly(G) ( ). Native 
poly(G) served as control. 
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Fig. 5. UV absorption spectra of native poly(G) (—), ROS-poly(G) ( -) , 
poIy(C) ( ), poly(G).poly(C) ( ) and ROS-poly(G).poly(C) ( ). 
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TABLE 3 
UV Absorption Characteristics of Native and ROS-poIy(G) and 
Their Complex with Poly(C) 
Polymer kmmx Absorbance ratio 
On") (AJAjJ 
Poly(G) 253 1.82 
ROS-poly(G) 253 1.70 
Poly(C) 269 1.29 
Poly(G).poly(C) 261 2.21 
ROS-poly(G).poly(C) 261 1.78 
45 
1.100 E +01 
-4.000 E+00 
220 260 300 
WAVELENGTH(nm) 
340 
Fig. 6. Circular dichroism spectra of native poly(G) ( 
( ) in PBS, pH 7.4. 
-) and ROS-poly(G) 
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shoulder at 285 nm. The minima and maxima of CD curve correspond to 238.8 nm and 
260.2 nm, respectively (Fig. 6). ROS-poly(G) shows negative ellipticity below 247 nm and 
positive ellipticity from 247 nm to 307 nm. The minima and maxima correspond to 261.4 nm and 
240 nm, respectively. The result showed 47% decrease in ellipticity of poly(G) after hydroxyl 
radical treatment. 
Thermal Melting of Poly(G) 
Thermally induced transitions of poly(G) were measured spectrophotometrically 
at their Xmii by heating the polymer at a rate of 1.5°C/min from 30°C to 95°C. 
The UV spectra was recorded simultaneously at 30°C and 95°C (Fig. 7). Table 4 
shows the absorbance ratio (A260/A280) at 30°C and 95°C. Native poly(G) and 
poly(G).poly(C) complex did not show significant change in absorbance at 30°C and 
95°C (Figs. 7a and c). The absorbance ratio (A260/A2g0) was found to be 1.82 and 
1.80 at 30°C and 95°C, respectively for native po ly(G) and 2.21 and 2.19 
respectively for poly(G).poly(C). These findings suggest the high stability of poly(G) 
due to its existence in multi-stranded form. The absorbance ratio of ROS-
poly(G).poly(C) was 1.78 at 30°C and 1.39 at 95°C, while for ROS-poly(G) it is 
1.70 and 1.59, respectively (Figs. 7b and d). The change in absorbance ratio of 
ROS-poly(G) and ROS-poly(G).poly(C) complex at 30°C and 95°C suggests 
structural alterations and a partial destruction of the secondary structure of poly(G) 
on ROS-modification. 
Strand Breaks 
(a) Sephadex G 200 Gel Filtration 
Figure 8 shows the gel chromatography profile of native and ROS-poly(G) on 
Sephadex G 200 column. Native poly(G) was eluted in a single, symmetrical sharp 
peak, while ROS-poly(G) showed an additional peak of low molecular weight. The 
minor peak may be attributed to the generation of strand breaks and consequent 
formation of smaller fragments of poly(G). The extent of modification was 
determined by measuring the peak area of the ROS-modified and unmodified 
poly(G). The data indicates the modification of poly(G) to an extent of 52.3%. 
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Fig. 7. UV absorption spectra of native and ROS-poly(G) and their complex with 
poly(C) at 30°C and 95°C. 
(a) Native poly(G) at 30°C ( ) and 95°C ( ). 
(b) ROS-poly(G) at 30°C ( ) and 95°C ( ). 
(c) Poly(G).poIy(C) at 30°C ( ) and 95°C ( ). 
(d) ROS-poly(G).poly(C) at 30°C ( ) and 95°C ( ). 
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TABLE 4 
Thermal Melting Characteristics of Native and ROS-poIy(G) and 
Their Complex with Poly(C) 
Polymer Absorbance ratio (\J\g^ 
at 30°C at 95°C 
Poly(G) 1.82 1.80 
ROS-Poly(G) 1.70 1.59 
Poly(G).poly(C) 2.21 2.19 
ROS-poly(G).poly(C) 1.78 1.39 
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8. Fractionation of native poly(G) ( O ) and ROS-poly(G) ( A ) on 
Sephadex G 200 gel filtration column. 
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(b) Densitometry Scanning of Native and ROS-Poly(G) 
Native and ROS-poly(G) were electrophoresed on 7.5% polyacrylamide gel 
and scanned on Gel Scanner GSC-3A of Shimadzu UV-240 spectrophotometer. 
Figure 9 shows the densitometric scanning of native and ROS-poly(G) at a fixed 
wavelength of 253 nm. ROS-poly(G) shows low intensity and high mobility than 
native poly(G). The data reflects the formation of low molecular weight species and 
strand breaks in poly(G) after hydroxyl radical modification. 
(c) Agarose Gel Electrophoresis 
The presence of strand breaks in hydroxyl radical modified poly(G) was 
ascertained by performing agarose gel electrophoresis of native and ROS-poly(G) in 
1% agarose gel. As evident from Figure 10, modified poly(G) migrated with 
enhanced mobility as compared to native poly(G). This difference in migration may 
be due to the changes in the secondary structure of modified poly(G) as opposed 
to the native poly(G). The enhanced mobility of ROS-poly(G) may also be 
attributed to the formation of low molecular weight species as a result of strand 
breaks. 
(d) Gel Diffusion of Native and ROS-Poly(G) 
To further ascertain the enhanced mobility of modified poly(G) due to the 
presence of strand breaks, gel diffusion experiment was performed. Native and 
ROS-poly(G) electrophoresed agarose gel was cut into strips and sliced into 0.5 cm 
pieces. The individual slices were extracted by diffusion, clarified by membrane 
filtration and read at 253 nm. The elution profile of ROS-poly(G) shows a shift in 
the peak fraction relative to native poly(G) (Fig. 11). The data clearly indicate the 
enhanced mobility of ROS-poly(G) in comparison to native poly(G) which might be 
due to the formation of strand breaks after ROS-modification. 
Quantitation of Modified Guanine Base 
Poly(G) was subjected to acid hydrolysis in order to separate the guanine 
base from the sugar-phosphate backbone. UV absorption spectra of acid hydrolysed 
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LENGTH OF GEL(Cm) 
Fig. 9. Densitometric scanning of native poly(G) ( ) and ROS-poly(G) 
( ) on 7.5% native polyacrylamide gel. Inset: Polyacrylamide gel 
electrophoresis of native poly(G) (lane 1) and ROS-poly(G) (lane 2) on 
7.5% native gel. 
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Fig. 10. Agarose gel electrophoresis of native poly(G) (lane 1) and ROS-poly(G) 
(lane 2). Electrophoresis was carried out on 1% agarose for 2 hr at 30 
mA and stained with ethidium bromide. 
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Fig. 11. Elution profile of native poly(G) ( O ) and ROS-poly(G) ( A ) fro 
agarose gel by diffusion. 
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native and ROS-poly(G) showed a distinct peak at 273 nm, a characteristic feature 
of guanine base (Fig. 12). This shift in Xmtx from 253 nm of poly(G) or ROS-
poly(G) to 273 nm indicates the release of guanine residues from the sugar-
phosphate backbone of poly(G) after acid hydrolysis. UV absorption spectra of 
guanine base released from ROS-poly(G) showed broadening of absorption maxima 
at 273 nm in contrast to a sharp peak of the base from native poly(G). The 
broadening of peak suggests structural alterations of guanine residues in poly(G) 
after ROS-modification. 
The neutralized hydrolysate of native and ROS-poly(G) was applied to a 
DEAE Sephadex A-25 column and eluted with a linear gradient of 1-20 mM Tris 
HC1, pH 7.6. Figure 13a shows the elution profile of standard guanine base. The 
elution profile of native poly(G) hydrolysate was similar to that of standard guanine 
base, while ROS-poly(G) eluted in two peaks (Fig. 13b). The major and minor 
peak represents modified and unmodified guanine base, respectively. The modified 
guanine base eluted first followed by unmodified species. The extent of modification 
as determined by measuring the peak area shows 76% modification of guanine base. 
Antigenicity of Native and ROS-Poly(G) 
The antigenicity of native and ROS-poly(G) was probed by inducing 
antibodies in rabbits. Direct binding ard inhibition ELISA were used to evaluate the 
repertoire of specificities of the induced antibodies. The binding of these antibodies 
to the immunogen was further assessed by band shift assay. 
(a) Antibodies Against Native Poly(G) 
The antiserum against native poly(G) in rabbits induced non-precipitating 
antibodies as determined by immunodiffusion and counterimmunoelectrophoresis. 
Direct binding ELISA on plates coated with native poly(G) indicated high binding 
activity with different serum dilutions showing a titre of atleast 1:6400 (Fig. 14). 
Preimmune serum showed negligible binding. Induced antibodies were found to be 
highly specific for the immuncgen. Inhibition ELISA showed a maximum of 67% 
inhibition of antibody binding to native poly(G) (Fig. 15). Fifty percent inhibition 
was achieved with only 1.5 \xg/m\ of poly(G). 
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Fig. 12. UV absorption spectra of native poly(G) ( ), ROS-poly(G) ( ), 
standard guanine base ( ) and acid hydrolysed native poly(G) 
( ) and ROS-poly(G) ( ). 
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Fig. 13. Elution profile of (a) standard guanine base ( O ) and (b) acid 
hydrolysed native poly(G) ( • ) and ROS-poly(G) ( A ) on DEAE 
Sephadex A-25 column. ROS-poly(G) eluted in two peaks, major peak 
represents modified guanine base and minor peak represent unmodified 
guanine base. 
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Fig. 14. Direct binding ELISA of immune ( A , • ) and preimmune ( O ) rabbit 
serum antibodies to native poly(G). Microtitre plates were coated with 
native poly(G) (5 ug/ml). 
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Fig. 15. Inhibition of the binding of anti-native poly(G) antibody (serum) ( O ) 
and affinity purified IgG ( A ) by native poly(G). Microtitre plates 
were coated with native poly(G) (5 ug/ml). 
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(b) Antibodies Against ROS-poly(G) 
ROS-poly(G) was highly immunogenic in rabbits. The antiserum showed a 
titre of 1:6400 by direct binding ELISA on plates coated with ROS-poly(G) (Fig. 
16). The binding of preimmune serum was of low magnitude. In competition 
inhibition assay, a maximum of 64% inhibition was observed and 50% inhibition was 
achieved with 9 ug/ml of ROS-poly(G) (Fig. 17). 
(c) Purification and Characterization of Immune IgG 
Anti-native and ROS-poly(G) IgG was isolated from serum by affinity 
chromatography on Protein A-Sepharose CL-4B column (Figs. 18a and b). The 
purity of IgG was ascertained by SDS-PAGE under non-reducing conditions (Figs. 
18a and b, inset), moving as a single homogeneous band. 
Direct binding ELISA of the purified IgG against poly(G) and ROS-poly(G) 
exhibited a strong binding to respective immunogens (Figs. 19 and 20). Preimmune 
IgG as negative control showed negligible binding. The specificity of the purified 
IgG was evaluated by competitive inhibition assays. A maximum of 71% inhibition 
of anti-native poly(G) IgG and 77% of anti-ROS-poly(G) IgG binding to the solid 
phase bound respective immunogen was observed with the immunogens as inhibitors 
(Figs. 15 and 17). Fifty percent inhibition in the corresponding antibody activity 
was achieved with only 0.1 ug/ml of native poly(G) and 0.7 ug/ml of ROS-poly(G) 
respectively. The data shows the definite antigen binding characteristics of purified 
IgG. 
Immunocrossreactivity of Anti-Native Poly(G) Antibodies 
The anti-native poly(G) antibodies exhibited a broad spectrum of reactivity as 
observed by its binding to a variety of nucleic acid antigens. Competitive 
experiments with ROS-poly(G) showed 57% inhibition in the antibody activity (Fig. 
21a). Fifty percent inhibition was achieved with 3.0 ug/ml of ROS-poly(G). Total 
RNA from buffalo thymus and calf thymus DNA showed moderate inhibitions of 
45% and 41% respectively. Their ROS-modified forms showed only 38% and 30% 
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Fig. 16. Direct binding ELISA of immune ( A , A ) and preimmune ( O ) rabbit 
serum antibodies to ROS-poly(G). Microtitre plates were coated with 
ROS-poly(G) (5 ug/ml). 
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Fig. 17. Inhibition of the binding of anti-ROS-poly(G) antibody (serum) ( o ) 
and affinity purified IgG ( A ) by ROS-poly(G). Microtitre plates were 
coated with ROS-poly(G) (5 ug/ml). 
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FRACTION NUMBER 
Elution profile of (a) anti-native poly(G) IgG and (b) anti-ROS-poly(G) 
IgG on Protein A-Sepharose 4B affinity column. Insets: SDS-PAGE of 
purified IgG on 7.5% acrylamide gel. 
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Fig. 19. Binding of affinity purified anti-native poly(G) IgG ( A ) and 
preimmune IgG ( A ) to native poly(G). Microtitre plates were 
coated with native poly(G) (5 ug/ml). 
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20. Binding of affinity purified anti-ROS-poly(G) IgG (A ) and preimmune 
IgG ( A ) to ROS-poly(G). Microtitre plates were coated with ROS-
poly(G) (5 ug/ml). 
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21. Inhibition of anti-native poly(G) IgG binding to native poly(G). Microti tre 
plates were coated with native poly(G) (5 ng/ml).The competitors were 
(a) ROS-poly(G) ( O ), RNA ( A ), DNA ( • ) and (b) ROS-
guanine ( O ), ROS-RNA ( A ), ROS-DNA ( A ). 
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inhibition respectively (Fig. 21b). The nitrogeneous base guanine showed 45% 
inhibition of antibody activity (Fig. 22a), and ROS-guanine shows 42% inhibition 
(Fig. 21b). Homopolymers poly(I) and poly(C) were non-inhibitory (Fig. 22a). 
Antibody recognition of poly(rG).poly(dC), a polymer known to attain A-/analogous 
conformation, resulted in 46% elimination of antibody binding (Fig. 22b). 
To further study the structural determinants recognized by anti-native poly(G) 
antibodies, their interaction with various synthetic polydeoxyribonucleotides was 
studied. Poly(dA-dT).poly(dA-dT) and poly(dA-dU).poly(dA-dU) showed a maximum 
inhibition of 42% and 33% respectively (Fig. 22b), while poly(dI-dC).poly(dI-dC), 
poly(dG-dC).poly(dG-dC) and poly(dA-dG).poly(dC-dT) showed negligible inhibition 
(Fig. 23). Table 5 shows a summary of the data on the binding characteristics of 
anti-native poly(G) IgG as determined by inhibition ELISA. 
Immunocrossreactivity of Anti-ROS-Poly(G) Antibodies 
Competition experiments of anti-ROS-poly(G) antibodies with a variety of 
nucleic acid polymers showed a wide range of heterogeneity. Native poly(G) showed 
a maximum of 54% inhibition in the antibody activity. Fifty percent inhibition was 
achieved with 5.5 ug/ml of native poly(G) (Fig. 24a). Native calf thymus DNA and 
buffalo thymus RNA showed moderate inhibitions of 39% and 41% respectively 
(Table 6). Their ROS-modified forms were also used as inhibitors. ROS-DNA 
showed a maximum inhibition of 42%, while ROS-RNA was inhibitory to an extent 
of 55% (Fig. 24b). Fifty percent inhibition of antigen-antibody interaction was 
obtained with 14 ug/ml of ROS-RNA. Guanine showed negligible inhibition of 21%, 
while ROS-guanine was a potent inhibitor (Fig. 24b), showing a maximum inhibition 
of 56%. The amount of ROS-guanine required for 50% inhibition in the antibody 
activity was 17.5 ug/ml (Table 6). Among the homopolymers, poly(I) and poly(C) 
showed negligible inhibition of 18% and 31% respectively, while ROS-poly(I) 
showed moderate inhibition of 45% (Fig. 25a). Synthetic double stranded 
polydeoxyribonucleotides, poly(dI-dC).poly(dI-dC), poly(dA-dU).poly(dA-dU) and 
poly(dA-dT).poly(dA-dT) showed maximum inhibitions of 25%, 30% and 39% 
respectively (Fig. 25b). Table 6 summarizes the inhibition data of anti-ROS-poly(G) 
IgG and shows the preferential recognition of ROS-modified epitopes over their 
unmodified counterparts. 
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22. Inhibition of anti-native poly(G) IgG binding to native poly(G). Microtitre 
plates were coated with native poly(G) (5 ug/ml). The competitors 
were (a) poly(I) ( O ), poly (C) ( A ), guanine base ( A ) and 
(b) poly(rG).poly(dC) ( O ), poly(dA-dU).poly(dA-dU) ( A ), poly(dA-
dT).poly(dA-dT) ( A ). 
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Fig. 23. Inhibition of anti-native poly(G) IgG binding to native poly(G). The 
competitors were poly(dA-dG).poly(dC-dT) ( O ), poly(dG-dC).poly(dG-
dC) ( A ) and poly(dI-dC).poly(dI-dC) ( A ). Microtitre plates were 
coated with native poly(G) (5 ng/ml). 
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TABLE 5 
Antigenic Specificity of Anti-Native PoIy(G) Antibodies 
Inhibitor Maximum % inhibition Concentration for 
at 20 ug/ml 50% inhibition 
Oig/ml) 
Poly(G) 
ROS-poly(G) 
RNA 
ROS-RNA 
DNA 
ROS-DNA 
Guanine 
ROS-guanine 
Poly(I) 
Poly(C) 
Poly(rG).poly(dC) 
Poly(dA-dT).poly(dA-dT) 
Poly(dA-dU).poly(dA-dU) 
Poly(dI-dC).poly(dI-dC) 
Poly(dG-dC).poly(dG-dC) 
Poly(dA-dG).poly(dC-dT) 
71 
57 
45 
38 
41 
30 
45 
42 
21 
12 
46 
42 
33 
18 
16 
8 
Plates were coated with native poly(G) (5 ug/ml) 
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Fig. 24. Inhibition of anti-ROS-poly(G) IgG binding to ROS-poly(G). Microtitre 
plates were coated with ROS-poly(G) (5 ug/ml). The competitors were 
(a) native poly(G) ( O ), RNA ( A ), DNA ( • ) and (b) native 
guanine (A), ROS-guanine ( • ), ROS-RNA (A), and ROS-DNA ( O ). 
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TABLE 6 
Antigenic Specificity of Anti-ROS Poly(G) Antibodies 
Inhibitor Maximum % inhibition Concentration for 
at 20 ug/ml 50% inhibition 
Poly(G) 
ROS-poly(G) 
DNA 
ROS-DNA 
RNA 
ROS-RNA 
Guanine 
ROS-guanine 
Poly(I) 
ROS-poly(I) 
Poly(C) 
Poly(dI-dC).poly(dI-dC) 
Poly(dA-dU).poly(dA-dU) 
Poly(dA-dT).poly(dA-dT) 
54 
77 
39 
42 
41 
55 
21 
56 
18 
45 
31 
25 
30 
39 
Plates were coated with ROS-poly(G) (5 ug/ml). 
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25. Inhibition of anti-ROS-poly(G) IgG binding to ROS-poly(G). Microtitre 
plates were coated with ROS-poly(G) (5 jig/ml). The competitors were 
(a) poly(C) ( A ), poly(I) ( O ), ROS-poly(I) ( A ) (b) poly(dI-
dC).poly(dl-dC) ( O ), poly(dA-dU).poly(dA-dU) ( A ) and poly(dA-
dT).(dA-dT) ( A ). 
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Band Shift Assay 
The binding of native and ROS-poly(G) to their immune IgG was further 
ascertained by band shift assay. Constant amounts of native and ROS-poly(G) were 
incubated with varying amounts of respective immune IgG for 2 hr at room 
temperature and overnight at 4°C. The immune complexes were then electrophoresed 
on 1% agarose for 2 hr at 30 mA. Figure 26 shows the formation of complexes 
between anti-native poly(G) IgG and native poly(G). With increasing concentration 
of IgG, the formation of high molecular weight immune complexes increased as 
judged by their fluorescence intensity, whereas, the amount of unbound poly(G) 
showed a proportional decrease in its intensity. The recognition of ROS-poly(G) by 
anti-ROS-poly(G) IgG was reiterated by the remarkable loss in fluorescence intensity 
of unbound ROS-poly(G) (Fig. 27). 
Detection of Anti-DNA Antibodies in SLE Sera 
Various SLE serum samples were tested for the presence of anti-DNA 
autoantibodies by ELISA. Figure 28 shows the binding of 1:100 diluted SLE serum 
to native DNA. Normal human serum shows negligible binding. The specificity of 
SLE autoantibodies binding to native DNA was determined by competition 
experiments. Native DNA showed maximum inhibitions ranging from 47% to 68% in 
eight SLE sera (Figs. 29a and b). Table 7 shows the inhibition data of anti-DNA 
autoantibodies binding to DNA from these serum samples. 
Reactivity of Anti-DNA Antibodies with Native and ROS-PoIy(G) 
The binding of SLE anti-DNA autoantibodies to native and ROS-poly(G) was 
determined by direct binding ELISA. All the eight SLE sera showed stronger 
binding to native and ROS-poly(G) with preferential binding to ROS-poly(G). Figure 
30 shows 10% to 35% higher absorbance values for ROS-poly(G) than native 
poly(G) in all serum samples. No binding was observed with the sera of normal 
subjects. 
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Fig. 26. Band shift assay of anti-native poly(G) IgG binding to native poly(G). 
Native poly(G) (5 ug) were incubated with buffer (lane 1) and 25, 50, 75 
and 100 ug IgG through lanes 2 to 5, respectively for 2 hr at 37°C and 
overnight at 4°C. Electrophoresis was performed on 1% agarose for 2 hr 
at 30 mA. 
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Fig. 27. Band shift assay of anti-ROS-poly(G) IgG binding to ROS-poly(G). ROS-
poly(G) (5 ug) were incubated with buffer (lane 1) and 25, 50, 75 and 
100 ug IgG through lanes 2 to 5, respectively for 2 hr at 37°C and 
overnight at 4°C. Electrophoresis was performed on 1% agarose for 2 hr 
at 30 mA. 
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Fig. 28. Binding of 1:100 diluted SLE serum samples to native DNA ( | | ). 
Normal human serum (NHS) showed negligible binding. Microtitre plates 
were coated with native DNA (2.5 ug/ml). 
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Fig. 29. Inhibition of SLE anti-DNA autoantibodies binding by native DNA. 
Microtitre plates were coated with native DNAJ^BJRBlS^feU) SLE sera 
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TABLE 7 
Inhibition in the Binding of Autoantibodies from SLE Sera 
by Native DNA 
SLE serum 
1 
2 
3 
4 
5 
6 
7 
8 
Maximum % inhibition 
at 20 ug/ml 
59 
47 
56 
59 
58 
68 
53 
63 
Concentration for 
50% inhibition 
Qig/ml) 
12 
-
12 
9 
14 
11 
18 
13 
Plates were coated with native DNA (2.5 ^ ig/ml). 
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Fig. 30. Binding of 1:100 diluted SLE serum samples to native poly(G) ( H ) 
and ROS-poly(G) ( H ). Normal human sera (NHS) showed negligible 
binding with either of the antigen. Microtitre plates were coated with 5 
ug/ml of respective antigens. 
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The specificity of each SLE serum for native and ROS-poly(G) was evaluated 
by inhibition assays (Figs. 31 and 32). In this case, the antibody was first incubated 
with native or ROS-poly(G) and then assayed for residual binding to double 
stranded DNA. The microtitre plates were coated with native DNA. Native poly(G) 
showed maximum inhibitions ranging from 31% to 57% in eight SLE sera (Table 
8). ROS-poly(G) showed relatively high percent inhibition in six SLE sera. One of 
these sera was inhibitory to an extent of 73%. Rest of the two sera showed low 
inhibitions of 29% and 31%, respectively. 
Purification of SLE IgG 
SLE IgG was purified by affinity chromatography on Protein A-Sepharose 
CL-4B column. Protein A has been known to bind IgG from most of the 
mammalian species. SDS-PAGE of purified IgG under non-reducing conditions 
showed a single homogeneous band. 
In order to investigate the binding activity of purified SLE IgG with native 
and ROS-poly(G), direct binding ELISA was performed. Figure 33 shows an 
appreciable binding of SLE IgG to native and ROS-poly(G), while normal human 
IgG showed negligible binding. 
Band Shift Assay 
Band shift assay was employed to further confirm and visualize the 
interaction of native and ROS-poly(G) with SLE autoantibodies. A constant amount 
of the antigen was incubated with increasing amounts (0-120 ug) of SLE IgG for 2 
hr at 37°C and overnight at 4°C. These immune complexes were then 
electrophoresed on 1% agarose for 2 hr at 30 mA. Figures 34 and 35 shows the 
binding of anti-DNA autoantibodies to native poly(G) and ROS-poly(G) respectively. 
With increasing concentration of IgG there is corresponding increase in the 
formation of high molecular weight immune complexes which resulted in retarded 
mobility and corresponding decrease in the fluorescence intensity of unbound 
antigen. Normal human IgG incubated under identical conditions did not show 
immune complex formation. 
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Fig. 31. Inhibition of SLE anti-DNA autoantibody binding by native and ROS-
poly(G). Microtitre plates were coated with native DNA (2.5 ug/ml). (a) 
SLE sera 1 and 2 by native poly(G) ( O . A ) and ROS-poly(G) ( A , # ) 
respectively, (b) SLE sera 3 and 4 by native poly(G) (O.A) and ROS-
poly(G) ( A , # ) respectively. 
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Fig. 32. Inhibition of SLE anti-DNA autoantibody binding by native and ROS-
poly(G). Microtitre plates were coated with native DNA (2.5 ug/ml) (a) 
SLE sera 5 and 6 by native poly(G) ( o , A ) and ROS-poly(G) (A • ) 
respectively, (b) SLE sera 7 and 8 by native poly(G) (O.A) and ROS-
poly(G) ( A , # ) respectively. 
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TABLE 8 
Inhibition of Anti-DNA Autoantibodies Binding to Native DNA by 
Native and ROS-Poly(G) 
SLE serum Maximum percent inhibition at 20 ug/ml 
Native poly(G) ROS-poly(G) 
1 41 73 
2 34 37 
3 54 63 
4 44 54 
5 57 62 
6 40 31 
7 31 39 
8 37 29 
Plates were coated with native DNA (2.5 ng/ml). 
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33. Binding of affinity purified SLE IgG to native poly(G) ( A ) and 
ROS-poly(G) ( A ). Normal human IgG ( O ) to either of the antigen 
(5 ug/ml). 
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Fig. 34. Band shift assay of SLE IgG binding to native poly(G). Native poly(G) (5 
Ug) were incubated with buffer (lane 1) and 30, 60, 90 and 120 ug IgG 
through lanes 2 to 5, respectively for 2 hr at 37°C and overnight at 4°C. 
Electrophoresis was performed on 1% agarose for 2 hr at 30 mA. 
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Fig. 35. Band shift assay of SLE IgG binding to ROS-poly(G). ROS-poly(G) (5 
ug) were incubated with buffer (lane 1) and 30, 60, 90 and 120 ug IgG 
through lanes 2 to 5, respectively for 2 hr at 37°C and overnight at 4°C. 
Electrophoresis was performed on 1% agarose for 2 hr at 30 mA. 
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Detection of Autoantibodies in PSS Sera 
Direct binding ELISA results showed the presence of high titre anti-DNA 
antibodies (Figs. 36 and 37) and anti-poly(G) autoantibodies (Figs. 38 and 39) in 
sera from eight patients with PSS. In contrast, no binding was observed with the 
sera from normal subjects. 
The specificity of the binding of native and ROS-poly(G) to PSS sera was 
tested using native poly(G) as an antigen in a competition assay. The results 
obtained are tabulated in Table 9. ROS-poly(G) effectively inhibited the PSS 
autoantibodies as compared to native poly(G). It was observed that from eight 
samples tested, native poly(G) showed inhibitions less than 50%, ranging between 
33% and 46%. ROS-poly(G) showed inhibitions greater than 50% in six out of 
eight PSS sera i.e., 57%, 61%, 53%, 51%, 60% and one sera showed high 
inhibition of 73%. Two sera exhibited lower inhibitions of 46% and 41% (Figs. 40 
and 41). These results suggests that oxygen free radicals under certain conditions 
can lead to the formation of 8-hydroxyguanine residues in DNA and RNA and thus 
may generate its potential immunogenic forms and induce autoantibody production in 
SLE and PSS patients. 
PSS IgG was purified from serum by affinity chromatography an Protein A-
Sepharose CL-4B column. Band shift assay of native and ROS-poly(G) with PSS 
IgG resulted in retarded mobility, further strengthening the direct binding and 
inhibition results (Fig. 42 and 43). 
Detection of Precipitating Antibodies in SLE and PSS Sera 
In order to detect the presence of precipitating antibodies to native and 
ROS-poly(G) in SLE and PSS sera, counterimmunoelectrophoresis was performed. 
Out of twelve, eight SLE sera showed precipitin arc with native and ROS-poly(G) 
(Fig. 44), whereas, all the eight PSS sera showed the presence of precipitating 
antibodies to native and ROS-poly(G) (Fig. 45). No precipitin line was observed 
with normal human sera. 
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Fig. 36. Direct binding ELISA of PSS serum autoantibodies to native DNA. PSS 
sera 1, 2, 3 and 4 ( • , A , 0 , # ) and normal human sera ( V )• 
Microtitre plates were coated with native DNA (2.5 ug/ml). 
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Fig. 37. Direct binding ELISA of PSS serum autoantibodies to native DNA. PSS 
sera 5, 6, 7 and 8 ( • , A , 0 , # ) and normal human sera ( v ) 
Microtitre plates were coated with native DNA (2.5 ng/ml). 
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38. Direct binding ELISA of PSS serum autoantibodies to native poly(G). PSS 
sera 1, 2, 3 and 4 ( A , A , 0 ,#) and normal human sera ( V ). 
Microtitre plates were coated with native poly(G) (5 ug/ml). 
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39. Direct binding ELISA of PSS serum autoantibodies to native poly(G). PSS 
sera 5, 6, 7 and 8 ( A , A . O , # ) and normal human sera ( V ) 
Microtitre plates were coated with native poly(G) (5 ug/ml). 
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TABLE 9 
Inhibition of the Binding of Antibodies from PSS Sera by Native 
and ROS-Poly(G) 
PSS serum Maximum percent inhibition at 20 ug/ml 
Native poIy(G) ROS-poIy(G) 
1 39 46 
2 35 57 
3 33 41 
4 42 61 
5 43 53 
6 38 51 
7 43 60 
8 46 73 
Plates were coated with native poly(G) (5 jig/ml). 
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Fig. 40. Inhibition of PSS serum autoantibody binding by native and ROS-poly(G). 
Microtitre plates were coated with native poly(G) (5 u,g/ml). (•) PSS sera 
1 and 2 by native poly(G) ( O . A ) and ROS-poly(G) ( A , # ) 
respectively, (b) PSS sera 3 and 4 by native poly(G) ( O . A ) and ROS-
poly(G) ( A , # ) respectively. 
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Fig. 41. Inhibition of PSS serum autoantibody binding by native and ROS-poly(G). 
Microtitre plates were coated with native poly(G) (5 ug/ml). (a) PSS sera 
5 and 6 by native poly(G) ( O . A ) and ROS-poly(G) ( A , » ) 
respectively, (b) PSS sera 7 and 8 by native poly(G) (OA) and ROS-
poly(G) ( A , # ) respectively. 
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Fig. 42. Band shift assay of PSS IgG binding to native poly(G). Native poly(G) 
(5 ug) were incubated with buffer (lane 1) and 30, 60, 90 and 120 ug 
IgG through lanes 2 to 5, respectively for 2 hr at 37°C and overnight at 
4°C. Electrophoresis was performed on 1% agarose for 2 hr at 30 mA. 
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Fig. 43. Band shift assay of PSS IgG binding to ROS-poly(G). ROS-poly(G) 
(5 ug) were incubated with buffer (lane 1) and 30, 60, 90 and 120 ug 
IgG through lanes 2 to 5, respectively for 2 hr at 37°C and overnight at 
4°C. Electrophoresis was performed on 1% agarose for 2 hr at 30 mA. 
97 
Lt 4 
( * ; o; 
Fig. 44. Counterimmunoelectrophoresis of SLE anti-DNA autoantibodies with native 
and ROS-poly(G). Arrow shows the formation of precipitin line. Normal 
human sera and SLE sera were placed in anodal well (wells 1 and 3, 
respectively), (a) Native poly(G) (2 ug) and (b) ROS-poly(G) (2 ug) 
were placed in cathodal well (wells 2 and 4, respectively). Electrophoresis 
was performed on 0.6% agarose gel for 1 hr at 4 mA. 
98 
W Cb3 
Fig. 45. Counterimmunoelectrophoresh of PSS serum autoantibodies with native and 
ROS-poly(G). Arrow shows the formation of precipitin line. Normal 
human sera and PSS sera were placed in anodal well (wells 1 and 3, 
respectively), (a) Native poly(G) (2 ug) and (b) ROS-poly(G) (2 jag) 
were placed in cathodal well (wells 2 and 4, respectively). Electrophoresis 
was performed on 0.6% agarose gel for 1 hr at 4 mA. 
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Detection of Immune Complex(es) Deposition in Kidney 
Rats immunized with native and ROS-poly(G) induced high titre antibodies as 
screened by direct binding ELISA (Figs. 46 and 47). Preimmune sera showed 
negligible binding, whereas, rats immunized with adjuvant only did not show 
significant binding with native and ROS-poly(G). Immunofluorescence of kidney 
sections of native and ROS-poly(G) immunized rats shows the deposition of immune 
complex(es) as revealed by an apple green fluorescence (Figs. 48 and 49). Kidney 
sections from control rats did not show any fluorescence. 
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Fig. 46. Direct binding ELISA of immune ( A , A , 0 , # ) , preimmune ( • ) and 
adjuvant immunized ( V , T ) rat serum antibodies to native poly(G). 
Microtitre plates were coated with native poly(G) (5 ug/ml). 
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Fig. 47. Direct binding ELISA of immune ( • , A , 0 , # ) , preimmune ( D ) and 
adjuvant immunized ( V , T ) rat serum antibodies to ROS-poly(G). 
Microtitre plates were coated with ROS-poly(G) (5 ng/ml). 
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48. Immunofluorescence of kidney sections from rats immunized with native 
poly(G). Dense granular mesangial IgG deposits with fine granular deposits 
of IgG involving some capillary walls were seen under fluorescent 
microscope, using anti-rat-FITC conjugate. 
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Fig. 49. Immunofluorescence of kidney sections from rats immunized with ROS-
poly(G). Immune complexes deposition in the glomerulus were seen 
under fluorescent microscope, using anti-rat-FITC conjugate. 
tMX4MW4l 
104 
Reactive oxygen species such as hydroxyl radical, superoxide radical, 
hydrogen peroxide and singlet oxygen are continuously produced during normal 
cellular metabolism. These highly reactive species are augmented after cellular 
exposure to ionizing radiation, carcinogens, cellular photosensitizers and certain 
metal catalysts among others, and have been implicated in a number of human 
degenerative diseases including aging, cancer (Halliwell, 1994; Knight, 1995; Loft 
and Poulsen, 1996) and inflammatory autoimmune diseases (Lunec et al., 1994). 
Amongst ROS, the hydroxyl radical is an extremely reactive oxidizing radical, 
formed in vivo via ionizing radiations (Breen and Murphy, 1995) or through Haber-
Weiss or Fenton reactions (Aruoma et al., 1991). These radicals have been known 
to interact indiscriminately with all components of the DNA molecule. A broad 
spectrum of DNA damage includes modification of all the four nitrogeneous bases 
leading to mutations, single and double strand breaks and apurinic sites (Halliwell 
and Aruoma, 1991). 
The lethal and mutagenic effects of ionizing radiation are postulated to be 
due to damage induced in DNA. A lesion implicated in cell death is the DNA 
double strand break produced from the passage of a single radiation track (Wolf et 
al., 1993). The apparently most abundant and certainly the most studied hydroxyl 
radical attack on DNA involves the C-8 hydroxylation of guanine base, the 8-oxo-
7,8-dihydro-2'-deoxyguanosine or 8-hydroxyguanine (8-OH-G) (Dizdaroglu, 1991; 
1994). 8-OH-G has been well established as an indicator of oxidative damage to 
calf thymus DNA exposed to a variety of oxygen generating systems including UV 
light (Beehler et al., 1992; Rosen et al, 1996). 
Human exposure to reactive oxygen species has been implicated in the 
etiology of a number of human autoimmune diseases, due to the formation of 
various modified DNA bases: the promutagenic lesion 8-OH-G, in particular, is a 
major product (Povey et al., 1993). The lesion induces a G to T transversion, 
suggesting that it is a mutation in DNA that might be a cause for carcinogenesis 
(Cheng et al., 1992; Musarrat and Wani, 1994; Rosen et al., 1996). Lymphocytes 
isolated from patients suffering from rheumatoid arthritis (RA) and systemic lupus 
erythematosus (SLE) also have been found to contain increased levels of 8-OH-G in 
DNA (Bashir et al., 1993). The level was found to be significantly high in SLE 
patients than in RA patients (Lunec et al., 1994). 
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In the present study, a ribohomopolymer, polyguanylic acid [poly(G)] was 
modified by hydroxyl radical, generated by irradiation of hydrogen peroxide with 
254 nm UV light. The modification of poly(G) includes the generation of strand 
breaks and modified guanine base. A substantial decrease in the absorption of 
poly(G) at Xmt%, 253 nm was observed with increasing duration of UV irradiation. 
This could be attributed to the fact that hydroxyl radicals are being continuously 
produced by UV irradiation, simultaneously causing damage to poly(G). The 
hypochromicity of ROS-poly(G) could be a result of structural modification of the 
guanine base. 
UV difference spectra of ROS-poly(G) with reference to native poly(G) 
shows a negat ive undefined peak at ^max, clearly indicating the marked 
hypochromicity of the modified polymer. This could be due to the structural 
alterations and modifications in guanine base. The positive peak in the negative 
range of UV difference spectra, shows the retention of sugar moieties of poly(G) 
after hydroxyl modifications. 
The structure of associated poly(G) has been shown by X-ray diffraction to 
exist in multistranded form (Zimmerman et al., 1975). Base stacking as well as 
hydrogen bonding are involved in stabilizing the native structure of poly(G). 
Poly(G) interacts with poly(C) to form an extremely stable poly(G).poly(C) complex. 
The change in absorbance ratio (A260/A280) from 1.82 in case of native poly(G) to 
1.7 for ROS-poly(G) and 2.21 for poly(G).poly(C) to 1.78 for ROS-poly(G).poly(C) 
complex suggests structural and conformational changes in hydroxyl radical modified 
poly(G). Circular dichroism spectra showed positive bands at 260 nm, and negative 
bands at 210 nm, a characteristic feature of A-form helix. There is no shift in the 
peaks of CD spectra indicating that no conformational transition has occurred in 
poly(G) after modification. The decrease in ellipticity of ROS-poly(G) indicated the 
reduced stacking of guanine base as a result of strand breaks. 
The thermal behaviour of self associated poly(G) was evaluated from the 
absorption data obtained by heating the polymer from 30°C to 95°C. UV absorption 
spectra of native poly(G) showed no considerable change in the absorbance ratio 
(A260/A2g0) at 30°C and 95°C (1.82 and 1.80, respectively), accounting for its high 
thermal stability. This is due to its existence in multi-stranded forms. The stacking 
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of guanine base in poly(G) is the basis of its stability, because it permits to form 
two hydrogen bonds per base compared with 1.5 bonds per base in the G.C pair 
of DNA. This additional hydrogen bond significantly enhances stability of the 
ordered poly(G) helices. The change in absorbance ratio of ROS-poly(G) from 1.7 
at 30°C to 1.59 at 95°C, point towards the destabilization of the interaction 
between guanine base and consequent helix disruption incurred by hydroxyl radical. 
An extremely high thermal stability of poly(G).poly(C) complex is due to the 
presence of an additional hydrogen bond between G.C pair of the double stranded 
homopolymer, compared to A.T pair. The change in absorbance ratio from 1.78 at 
30°C to 1.39 at 95°C of ROS-poly(G).poly(C) accounts for the instability of 
interaction between ROS-poly(G) and poly(C). These studies suggest that hydroxyl 
radical is somehow imparting instability to the helix in ROS-poly(G).poly(C) 
complex. 
Structural alterations in ROS-poly(G) are caused due to simultaneous scission, 
resulting in the formation of strand breaks, disruption of hydrogen bonding leading 
to destabilization of guanine base stacking. These results are in agreement with 
earlier reports where, photo-ionization of polynucleotides and DNA could lead to 
the formation of electron loss centres localized at the guanine moiety (Candeias et 
al., 1992). Strand breaks have been known to be induced in poly(G) by sulphate 
radical anion (Wolf et al, 1993). 
The generation of strand breaks in poly(G) incurred by hydroxyl radical was 
studied by Sephadex G 200 gel chromatography. Unmodified poly(G) eluted in a 
single symmetrical peak indicating the ordered form of poly(G). In contrast, ROS-
poly(G) eluted in two peaks. The first peak corresponds to the peak obtained for 
native poly(G) whereas, the second peak constitutes 52.3% of total ROS-poly(G) 
applied to the column. This additional peak may be attributed to the generation of 
strand breaks, disruption of hydrogen bonding between guanine bases, leading to the 
formation of low molecular weight species which eluted as a second peak. 
The presence of strand breaks in ROS-poly(G) was further ascertained by 
densitometric scanning of native and ROS-poly(G) following electrophoresis on 7.5% 
native acrylamide gel. Low intensity of ROS-poly(G) attribute the destruction of 
guanine base. High mobility indicate the formation of strand breaks in poly(G). 
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The observed effects on the mobili ty of poly(G) under non-denaturing 
conditions suggest that a difference in the migration between native and modified 
poly(G) may be a consequence of hydrogen peroxide exposure. The resulting 
electrophoretic patterns were characterized by fast (modified) and slow (native) 
moving components, possibly representing strand scission in poly(G). Thus hydrogen 
peroxide in presence of UV light seems to affect the secondary structure of 
poly(G). 
The agarose gel electrophoretic pattern of native and ROS-poly(G) was 
further analyzed by their elution profile after extraction from agarose gel. The 
modified poly(G) showed a shift in peak fraction, thereby implicating the enhanced 
mobility due to fragmentation of poly(G). 
In addition to the alterations within sugar phosphate backbone, hydroxyl 
radicals have been known to cause extensive damage to guanine moieties of DNA 
producing 8-hydroxyguanine (Lunec et al., 1994). In order to determine the 
participation of hydroxyl radical in mediating alterations in guanine residue, the UV 
spectra of acid hydrolysed native and modified poly(G) were compared. A distinct 
peak at 273 nm clearly indicated the release of guanine base from the sugar 
phosphate backbone of poly(G). The broadening of absorption maxima of ROS-
poly(G) at 273 nm, in contrast to the sharp peak [of native poly(G)] suggests that 
hydroxyl radical causes structural perturbations of the guanine residues. Elution 
profile of acid hydrolysed ROS-poly(G) on DEAE Sephadex A 25 column showed 
75.8% modification of guanine base.These results are consistent with earlier studies 
which demonstrate greater susceptibility of guanine modification by hydroxyl radical 
leading to the formation of 8-OH-G (Rosen et al, 1996; Tritscher et al, 1996). 
Native DNA per se is known to be a poor immunogen (Madio et al., 1934; 
Stollar, 1986), whereas, double stranded RNA, RNA-DNA hybrids, double helical 
polydeoxyribonucleotides, r ibohomopolymers, poly(G), poly(I), poly(U), DNA 
modified with drugs, hormones, chromatin or DNA in complexes with DNA binding 
proteins induce antibodies (Stollar, 1973; 1975; 1986; Anderson et al., 1988; Desai 
et al., 1993; Moinuddin and Ali, 1994; Arjumand et al., 1995; Hasan et al., 1995; 
Theofilopoulous, 1995; Arif and Ali, 1996; Arjumand et al., 1997). Recent evidence 
suggests that DNA from various species differ in their immunological activity and 
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that bacterial DNA can induce the in vitro proliferation of normal murine B cells 
(Messina et al., 1993). The mitogenic activity of DNA is dependent on sequence-
specific determinants that can be presented by synthetic DNA duplexes (GC-rich 
region) as well as bacterial single stranded and double stranded DNA, suggesting 
that DNA regions enriched in GC content have enhanced immunological activity. 
Reactive oxygen species modified DNA have been implicated in the pathogenesis of 
SLE (Ara and Ali, 1992; 1993; 1995; Ahmad et al., 1997; Cooke et al., 1997). 
The present studies demonstrated the fine immunogenicity of a ribohomopolymer, 
polyguanylic acid [poly(G)] and its hydroxyl radical modified counterpart i.e., ROS-
poly(G). The unique property of poly(G) is its existence in multistranded form, 
most probably the quadruple-strand. X-ray diffraction pattern of polyguanylic acid 
indicated a four-stranded structure (Zimmerman et al., 1975; Simard and Savoie, 
1994). 
Both the native and ROS-poly(G) were found to be highly immunogenic in 
rabbits as revealed by direct binding and inhibition ELISA results. Band shift assay 
clearly demonstrated the absolute specificity of the purified immune IgG towards 
their respective immunogen. The fine antigenic specificity of purified IgG was 
confirmed by inhibition ELISA. 
A maximum of 67% inhibition of anti-native poly(G) antibody (serum) binding 
to native poly(G) was observed. Fifty percent inhibition in the antibody activity was 
achieved with 1.5 ug/ml of poly(G). Purified anti-native poly(G) IgG was inhibited 
to an extent of 71% and 50% inhibition was observed with only 0.1 ug/ml of 
native poly(G). The data clearly indicate the higher specificity of purified IgG as 
compared to serum activity towards native poly(G). ROS-poly(G) showed a 
maximum inhibition of 57%. Buffalo thymus RNA and calf thymus DNA showed 
45% and 41% inhibitions respectively, whereas, their ROS-modified forms showed 
lower inhibitions of 38% and 30% respectively. The data indicate the specificity of 
IgG towards the native form of conformers than their ROS-modified forms, 
preferably recognizing the phosphodiester-ribose backbone than the phosphodiester-
deoxyribose backbone. Inhibition studies by a nitrogeneous base guanine, double 
stranded polynucleotides, poly(dA-dT).poly(dA-dT), poly(dA-dU).poly(dA-dU), 
poly(rG).poly(dC) shows the polyreactivity of the induced antibodies. Higher 
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inhibitions by unmodified poly(G), DNA, RNA, and guanine as compared to their 
ROS-modified forms suggest that ROS-modification alters the antigenic determinants. 
This broad polyspecificity of the induced antibodies with a variety of 
polynucleotides might be due to the recognition of the phosphodiester-backbone 
(Ballard and Voss, 1982; Rauch et al., 1985). 
Purified anti-ROS-poly(G) IgG showed a maximum inhibition of 77% (64% 
with serum) with ROS-poly(G). Fifty percent inhibition was attained with only 0.7 
ug/ml of ROS-poly(G) (9 ug/ml in case of serum). This indicates the higher 
specificity of purified immune IgG than serum activity. Inhibition data showed wide 
crossre activity of IgG with various nucleic acid polymers. ROS-modified DNA, 
RNA, poly(I) and guanine showed higher inhibitions (42%, 55%, 45% and 56% 
respectively) than their unmodified counterparts (39%, 41%, 18% and 21% 
respectively). The data shows the preferential recognition of ROS-modified part of 
the polymer, and cross reactivity is due the presence of common epitope, the 
phosphodiester backbone. 
ROS-guanine showed a high inhibitory potential of 56% than native guanine 
(21%). This indicates that the immune IgG is more specific to the ROS-modified 
epitopes on guanine. Earlier reports demonstrated guanine to be highly susceptible 
to "OH modification leading to the formation of 8-OH-G (Lunec et al., 1994). 
Modification of guanine by ROS could, therefore, generate potential epitopes against 
which antibodies are elicited. 
Autoantibodies targeted against intracellular proteins and nucleic acids are the 
serologic hallmarks of the systemic rheumatic diseases, such as systemic lupus 
erythematosus (SLE), progressive systemic sclerosis (PSS), Sjogren's syndrome (SS), 
mixed connective tissue disease (MCTD), and polymyositis (PM). Each of these 
diseases are identified by unique autoantibodies (Fritzler, 1996). The present study 
was designed in view of progressive increase of autoantibodies against polyguanylic 
acid in systemic lupus erythematosus and progressive systemic sclerosis. Recent 
studies postulated that ROS-modified DNA elicits a more discriminating antigen for 
the diagnosis of SLE (Blount et al, 1990; 1991; Ara and AH, 1992, 1995; Ahmad 
et al., 1997; Cooke et al., 1997). The detection of 8-OH-G in the immune 
complex derived DNA of SLE (Lunec et al., 1994) reinforces the evidence that 
ROS may be involved in SLE. 
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Two groups of patient with the inflammatory conditions of SLE and PSS 
were used to study the role of ROS-induced damage to a ribohomopolymer of 
guanine base, poly(G), in inflammation. Patients with SLE have diverse clinical 
manifestations including arthritis, vasculitis, skin rashes and renal complications, and 
the disease is notable for the wide variety of autoantibodies found in serum; anti-
double stranded DNA antibodies being the most specific serologic marker in SLE. 
An additional abnormality of SLE is the presence of circulating immune complexes 
(Lunec et al., 1994). 
Progressive systemic sclerosis is a generalized disorder of the connective 
tissue characterized by inflammatory, fibrotic, and degenerative changes accompanied 
by vascular lesions in skin, synovium and certain internal organs. PSS is 
serologically associated with the emergence of autoantibodies to SC1-70 (DNA 
topoisomerase I), to centromere/kinetochore protein and to nucleolar epitopes (RNA 
polymerase I, PM-SC1, U3-RNP) with different incidence and disease specificities 
(Ebert et al, 1997; Vazquez-Abad et al., 1997). 
In the present study, anti-double stranded DNA autoantibodies were screened 
from patients with SLE by direct binding and inhibition ELISA. An appieciable 
binding was seen with native DNA and inhibition results shows 47% to 68% 
inhibitions in the anti-DNA autoantibody binding to native DNA in eight different 
SLE sera. In order to investigate the involvement of guanine residues in the 
recognition of anti-DNA autoantibodies, native and modified poly(G) were used &s 
competitors. Direct binding ELISA results demonstrate the preferential rscognition of 
ROS-poly(G) over native poly(G) in all SLE serum samples. Native poly(G) showed 
maximum inhibitions ranging from 31% to 57%, whereas, ROS-poly(G) showed 
relatively high per cent inhibitions from 37% to 73% in six out of eight SLE sera. 
Band shift assay further substantiated the binding of native and modified poly(G) 
with anti-DNA autoantibodies. 
The results are consistent with earlier studies, in recognizing the guanine 
moieties of DNA by anti-DNA autoantibodies (Stollar et al., 1986; Zouali and 
Stollar, 1986). Furthermore, the preferential recognition of hydroxyl modified 
poly(G) could indicate the possible presence cf 8-OH-G in oxidatively damaged 
DNA, which may lead to mutations of GC to AT transitions (Emmerit et al., 
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1995). Therefore, oxidatively modified DNA having altered base guanine might be 
triggering immune stimulus and the antibodies thus generated represent circulating 
anti-DNA autoantibodies in SLE patients, cross reacting with native DNA. 
Avian scleroderma of UCD 200 chickens closely resembles human PSS in 
many pathomorphological, pathogenetic and serological aspects (Haynes and 
Gershwin, 1984; van de Water et al., 1984; van de Water and Gershwin, 1986; van 
de Water et al., 1989). The collagen and fibronectin deposition and the composition 
of the inflammatory infiltrate in the skin as well as quantitative and functional T 
cell deficiency in peripheral blood lymphocytes in UCD-200 have been demonstrated 
(Gruschwitz et al., 1991) to resemble human PSS. A progressive increase in 
autoantibodies to single stranded DNA, histones and less prominently to double 
stranded DNA have been detected. A similar pattern was also seen for antibodies 
to poly(G). The presence of anti-cardiolipin antibodies may be involved in the 
pathogenesis of PSS by causing vascular damage through inhibition of prostacyclin 
production in vascular endothelium (Carreras and Vermylen, 1982; Schorer et al., 
1989). 
Serum from PSS patients were investigated for the presence of autoantibodies 
to poly(G) and ROS-poly(G). Direct binding ELISA results showed the presence of 
high titre anti-poly(G) autoantibodies in all PSS sera. Furthermore, ROS-poly(G) 
inhibit the activity of PSS autoantibodies to a better extent than unmodified 
poly(G). Band shift assay reiterate the binding of native and ROS-poly(G) to 
purified PSS IgG. 
PSS and SLE were further investigated to determine the frequency of single 
stranded RNA antibodies, particularly the anti-poly(G) autoantibodies. All PSS sera 
showed the formation of precipitating immune complexes with native and ROS-
poly(G) by counterimmunoelectrophoresis, whereas, eight out of twelve SLE sera 
(67%) were positive by this technique. This could suggest the higher prevalence of 
anti-RNA antibodies in scleroderma which is due to ribose moiety of RNA and is 
quite distinct from those of anti-DNA antibodies in SLE (Alarcon-Segovia and 
Fishbein, 1975). 
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Anti-DNA autoantibodies are important contributors to glomerular immune 
deposit formation in individuals with systemic lupus erythematosus (Koffler et al., 
1967; Hahn, 1980; Wilson, 1991). It has been suggested that both the site of 
immune deposit formation and the resulting pathologic and clinical abnormalities 
may be dependent on properties unique to subsets of anti-DNA autoantibodies 
(Vlahakos et al., 1992) The lupus nephritis phenotype are dependent on both the 
inflammatory and antigen binding properties of the pathogenic autoantibody. 
Rats immunized with native and ROS-poly(G) induced high titre antibodies. 
Kidney sections of the immunized rats were used to detect the deposition of 
immune complexes in the glomerulus. Immunofluorescence revealed the deposition of 
immune complexes in the glomeruli of the kidney as evident by an apple green 
fluorescence. The immune complex deposition may cause kidney inflammation and 
tissue destruction. These findings could suggest that the antibody ligand interactions 
participate in immune deposit formation in individuals with lupus and the 
predominant autoantibody autoantigen interaction(s) influence both the morphologic 
and clinical expression of nephritis. 
These results demonstrate that the guanine residue of DNA and RNA are 
highly susceptible to ROS-mediated damage in the chronic inflammatory disorders, 
SLE and PSS. Earlier reports have demonstrated the formation of 8-OH-G in 
oxidatively damaged DNA, in inflammatory disorders including aging and cancer 
(knight, 1995; Loft and Poulsen, 1996). Therefore, it could be possible that 
oxidatively modified guanine base of DNA and RNA might be contributing towards 
the production of autoantibodies.Based on the above studies, the following 
conclusion can be drawn. 
1. Poly(G) modified with UV light (254 nm) in the presence of hydrogen 
peroxide resulted in the formation of strand breaks and modification of 
guanine base. 
2. Guanine was modified to an extent of 76%. 
3. Both the native and ROS-poly(G) were highly immunogenic in experimental 
animals. 
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The induced antibodies recognized a variety of native and modified nucleic 
acid polymers. 
Anti-native poly(G) antibodies preferentially recognize the native conformations 
of the polynucleotides as compared to their ROS-modified counterparts. 
Anti-ROS-poly(G) antibodies are more specific to ROS-modified epitopes than 
their native forms. 
The antigen binding behavior of anti-ROS-poly(G) antibodies resembles the 
binding characteristics of SLE anti-DNA autoantibodies. 
Anti-DNA autoantibodies showed preferential binding of ROS-poly(G) than 
native poly(G). 
ROS-poly(G) as compared to native DNA provides higher inhibitory potential 
to SLE anti-DNA autoantibodies which points out the presence of unique 
potential epitopes on modified poly(G), most probably due to the formation 
of 8-OH-G, a marker of oxidative DNA damage in SLE. 
Serum from PSS patients preferentially recognize ROS-poly(G) than native 
poly(G). 
High frequency of precipitating anti-poly(G) autoantibodies in PSS sera than 
SLE sera suggest the prevalence of anti-RNA antibodies in scleroderma. 
Rats immunized with native and ROS-poly(G) induced high titre antibodies. 
Kidney sections of native and ROS-poly(G) immunized rats showed the 
deposition of the immune comlexes in the glomeruli, by immunofluorescence. 
The possibility of oxidatively damaged guanine residues of DNA and RNA, 
acting as a stimuli in inducing lupus anti-DNA autoantibodies and anti-RNA 
autoantibodies in PSS could not be ruled out. 
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